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A B S T R A C T
Background
Current guidelines recommend performance of oesophago-gastro-duodenoscopy at the time of diagnosis of hepatic cirrhosis to screen
for oesophageal varices. These guidelines require people to undergo an unpleasant invasive procedure repeatedly with its attendant
risks, despite the fact that half of the people do not have identifiable oesophageal varices 10 years after the initial diagnosis of cirrhosis.
Video capsule endoscopy is a non-invasive test proposed as an alternative method for the diagnosis of oesophageal varices.
Objectives
To determine the diagnostic accuracy of capsule endoscopy for the diagnosis of oesophageal varices in children or adults with chronic
liver disease or portal vein thrombosis, irrespective of the aetiology. To investigate the accuracy of capsule endoscopy as triage or
replacement of oesophago-gastro-duodenoscopy.
Search methods
We searched the Cochrane Hepato-Biliary Group Diagnostic Test Accuracy Studies Register (October 2013), MEDLINE (Ovid SP)
(1950 to October 2013), EMBASE (Ovid SP) (1980 to October 2013), ACP Journal Club (Ovid SP) (1991 to October 2013),
Database of Abstracts of Reviews of Effects (DARE) (Ovid SP) (third quarter), Health Technology Assessment (HTA) (Ovid SP) (third
quarter), NHS Economic Evaluation Database (NHSEED) (Ovid SP) (third quarter), and Science Citation Index Expanded (SCI-
EXPANDED) (ISI Web of Knowledge) (1955 to October 2013). We applied no language or document type restrictions.
Selection criteria
Studies that evaluated the diagnostic accuracy of capsule endoscopy for the diagnosis of oesophageal varices using oesophago-gastro-
duodenoscopy as the reference standard in children or adults of any age, with chronic liver disease or portal vein thrombosis.
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Data collection and analysis
We followed the available guidelines provided in the Cochrane Handbook for Diagnostic Test of Accuracy Reviews. We calculated the
pooled estimates of sensitivity and specificity using the bivariate model due to the absence of a negative correlation in the receiver
operating characteristic (ROC) space and of a threshold effect.
Main results
The search identified 16 eligible studies, in which only adults with cirrhosis were included. In one study, people with portal thrombosis
were also included.We classifiedmost of the studies at high risk of bias for the ’Participants selection’ and the ’Flow and timing’ domains.
One study assessed the accuracy of capsule endoscopy for the diagnosis of large (high-risk) oesophageal varices. In the remaining15
studies that assessed the accuracy of capsule endoscopy for the diagnosis of oesophageal varices of any size in people with cirrhosis,
936 participants were included; the pooled estimate of sensitivity was 84.8% (95% confidence interval (CI) 77.3% to 90.2%) and
of specificity 84.3% (95% CI 73.1% to 91.4%). Eight of these studies included people with suspected varices or people with already
diagnosed or even treated varices, or both, introducing a selection bias. Seven studies including only people with suspected but unknown
varices were at low risk of bias; the pooled estimate of sensitivity was 79.7% (95% CI 73.1% to 85.0%) and of specificity 86.1% (95%
CI 64.5% to 95.5%). Six studies assessed the diagnostic accuracy of capsule endoscopy for the diagnosis of large oesophageal varices,
associated with a higher risk of bleeding; the pooled sensitivity was 73.7% (95% CI 52.4% to 87.7%) and of specificity 90.5% (95%CI
84.1% to 94.4%). Two studies also evaluated the presence of red marks, which are another marker of high risk of bleeding; the estimates
of sensitivity and specificity varied widely. Two studies obtained similar results with the use of a modified device as index test (string
capsule). Due to the absence of data, we could not perform all planned subgroup analyses. Interobserver agreement in the interpretation
of capsule endoscopy results and any adverse event attributable to capsule endoscopy were poorly assessed and reported. Only four
studies evaluated the interobserver agreement in the interpretation of capsule endoscopy results: the concordance was moderate. The
participants’ preferences for capsule endoscopy or oesophago-gastro-duodenoscopy were reported differently but seemed in favour of
capsule endoscopy in nine of 10 studies. In 10 studies, participants reported some minor discomfort on swallowing the capsule. Only
one study identified other significant adverse events, including impaction of the capsule due to previously unidentified oesophageal
strictures in two participants. No adverse events were reported as a consequence of the reference standard.
Authors’ conclusions
We cannot support the use of capsule endoscopy as a triage test in adults with cirrhosis, administered before oesophago-gastro-
duodenoscopy, despite the low incidence of adverse events and participant reports of being better tolerated. Thus, we cannot conclude
that oesophago-gastro-duodenoscopy can be replaced by capsule endoscopy for the detection of oesophageal varices in adults with
cirrhosis. We found no data assessing capsule endoscopy in children and in people with portal thrombosis.
P L A I N L A N G U A G E S U M M A R Y
Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
Background
In cases of hepatic cirrhosis, whatever the cause, the changes in the structure of, and blood flow within, the liver increase the pressure
in the portal vein (called portal vein hypertension), which is the vein that drains blood from the bowels to the liver. Portal hypertension
induces dilation (opening) of veins within the wall of the oesophagus (food pipe or gullet), which often rupture (break) with severe
bleeding. Thus, when liver cirrhosis is diagnosed, an oesophago-gastro-duodenoscopy (OGD) is recommended to detect the presence
of oesophageal varices (areas of abnormal dilation of veins). During OGD, a small camera on the end of a tube is inserted down the
oesophagus from the mouth. This relays pictures back to a screen. The presence of large varices or of red-coloured signs on even small
varices identifies high risk of rupture and bleeding. If high-risk varices are found, treatment with beta-blockers is effective in reducing
the risk of bleeding. Capsule endoscopy is a less invasive test than OGD as participants have only to swallow a small device that is able
to produce images of the oesophageal walls and could be able to detect the presence of dilated veins.
Study characteristics
We searched scientific databases for clinical studies comparing OGD to capsule endoscopy and reporting the size and appearance of
varices in children or adults with chronic liver disease or portal vein thrombosis (narrowing of the portal vein). The evidence is current
to October 2013.
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Key results
We found 16 studies assessing the ability of capsule endoscopy to diagnose the presence of varices and grade the risk of bleeding and
comparing it with OGD in adults with cirrhosis. Capsule endoscopy, even if more acceptable to participants, cannot replace OGD for
the detection of oesophageal varices as about 15% are left undetected and 15% are not confirmed by endoscopy. Even the accuracy
in detecting large varices or red marks on varices was very lower than endoscopy. Hence, in conclusion, capsule endoscopy is not
sufficiently accurate to replace OGD for the detection of oesophageal varices in cirrhotic participants.
Quality of the evidence
In nine of the sixteen studies there were problems concerning participant selection and incompleteness of reported data which impair
accuracy estimates and the transferability of the results.
B A C K G R O U N D
Portal hypertension commonly accompanies advanced liver dis-
ease and often gives rise to life-threatening complications, includ-
ing haemorrhage from oesophageal and gastrointestinal varices.
The prevalence of cirrhosis in high-income countries ranges be-
tween 0.4% and 1.1% (Bellentani 1994; Quinn 1997); up to
two-thirds of people with cirrhosis develop gastro-oesophageal
varices (Garceau 1963; Jensen 2002). The prevalence of gastro-
oesophageal varices in people with cirrhosis increases by nearly 5%
per year (Merli 2003). Gastro-oesophageal varices are an extension
of oesophageal varices, and isolated gastric varices occurring in the
absence of oesophageal varices are rare and usually associated with
splenic vein thrombosis (Garcia-Tsao 2007).
As varices grow larger, they become more likely to rupture and
bleed (Lebrec 1980; NIEC 1988). Haemorrhage from ruptured
oesophageal varices is one of the most common causes of gastroin-
testinal bleeding and the most common cause of death in peo-
ple with cirrhosis (D’Amico 2006; Garcia-Tsao 2007). Studies by
the Northern Italian Endoscopic Club have shown that the fre-
quency of bleeding from large varices is 50% to 53% over two
years compared to 5% to 18% from small varices (NIEC 1988;
Zoli 1996). Up to 30% of the initial bleeding episodes are fa-
tal, and bleeding recurs in 70% of the survivors (Graham 1981;
NIEC 1988; Sharara 2001; D’Amico 2003; Bambha 2008). How-
ever, primary prophylaxis with non-selective beta-blockers or en-
doscopic variceal banding lowers the incidence of first variceal
haemorrhage, especially of medium-to-large varices (Garcia-Tsao
2008; Gluud 2012).
The American Association for the Study of the Liver Diseases rec-
ommend that medium-sized varices and large varices be managed
in the same way (Garcia-Tsao 2007). The guidelines recommend
oesophago-gastro-duodenoscopy for screening for oesophageal
varices “at the diagnosis of hepatic cirrhosis” (Garcia-Tsao 2007).
However, the point prevalence of oesophageal varices requiring
prophylaxis is about 15% to 25%, such that the majority of peo-
ple undergoing screening oesophago-gastro-duodenoscopy either
do not have varices or have varices that do not require treatment.
Moreover, oesophago-gastro-duodenoscopy is an invasive proce-
dure that requires sedation and is potentially associated with seri-
ous, even if rare, complications (Silvis 1976; Cotton 2006). There-
fore, there is a need to develop a cost-effective triage pathway to se-
lect people whowill benefit fromoesophago-gastro-duodenoscopy
screening.
A non-invasive test could play the role of a triage test if able to de-
tect people with very low probability of having oesophageal varices
accurately and hence reduce the use of endoscopy, reserving it
only for people with positive results. A non-invasive test may even
be more accurate than the reference standard, that is, oesophago-
gastro-duodenoscopy, and in such a case, it could replace the ref-
erence standard. However, for a non-invasive test to replace oe-
sophago-gastro-duodenoscopy as the preferred diagnostic test for
varices, it should accurately demonstrate the presence of varices
and also provide the other information that can be gained from
endoscopy. Importantly, it should be able to predict the risk of
variceal bleeding with as much or greater accuracy as oesophago-
gastro-duodenoscopy.
Target condition being diagnosed
Oesophageal varices
The presence of oesophageal varices of any size: oesophageal varices
are dilated blood vessels within the wall of the oesophagus that de-
velop when resistance to blood flow through the liver is increased,
due to cirrhosis or portal vein obstruction. Large oesophageal
varices are associated with greater risk of bleeding than varices of
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smaller size. Red marks (or red colour signs) on varices diagnosed
during oesophago-gastro-duodenoscopy have also been associ-
ated with increased bleeding risk (Garcia-Tsao 2007; Garcia-Tsao
2008). Medium varices were classified as large varices, as sug-
gested by the American Association for the Study of Liver Diseases
(Garcia-Tsao 2007), because the recommendations for manage-
ment of medium-sized varices are the same as for large varices.
Index test(s)
Capsule endoscopy
Video capsule endoscopy was originally designed for evaluation of
small bowel pathology and has now been adapted to evaluate the
oesophagus with the development of an oesophageal video capsule
that should be able to explore the oesophageal walls and detect the
presence of varices and describe their characteristics, such as size
and presence of red marks.
Clinical pathway
At the time of diagnosis of hepatic cirrhosis of whatever aetiology,
an oesophago-gastro-duodenoscopy is recommended in order to
detect the presence of oesophageal varices and to define the risk of
their rupture and bleeding. In the case of high-risk varices (large
varices or presence of red marks), primary prophylaxis with a non-
selective beta-blocker has been demonstrated to be effective and is
hence recommended. If oesophago-gastro-duodenoscopy reveals
no varices, then a repeated examination is recommended in three
years. If low-risk varices are seen (small varices without redmarks),
then oesophago-gastro-duodenoscopy should be repeated in two
years or if hepatic decompensation is present (Child-Pugh score
B-C) (Pugh 1973), then oesophago-gastro-duodenoscopy should
be repeated in one year (Garcia-Tsao 2007; Garcia-Tsao 2008).
Prior test(s)
The diagnosis of liver cirrhosis is usually based on clinical judge-
ment derived from history, laboratory test, physical examination,
imaging, liver histology, or a combination of these. No prior test is
recommended in the guidelines before screening with oesophago-
gastro-duodenoscopy of oesophageal varices when the diagnosis
of cirrhosis is made.
Role of index test(s)
The possible role of capsule endoscopy is to screen people with di-
agnosis of cirrhosis for the presence of varices, sparing oesophago-
gastro-duodenoscopy in people with negative results. Further-
more, capsule endoscopy could even replace oesophago-gastro-
duodenoscopy if its accuracy in detecting varices and defining
high-risk varices (large varices or presence of red marks) was equal
to that of oesophago-gastro-duodenoscopy.
Alternative test(s)
Some non-invasive tests have been proposed for the diagnosis
of oesophageal varices, such as serum markers for liver fibrosis,
platelet count, platelet count/spleen size ratio, transient elastogra-
phy or imaging with ultrasound computer tomography and mag-
netic resonance. We will examine each of these tests in future
planned reviews (Gana 2010a; Gana 2010b; Gana 2010c; Gana
2010d).
Rationale
The effective prevention of the first variceal haemorrhage (pri-
mary prophylaxis) in adults with medium or large varices can be
achieved using non-selective beta-blockers or endoscopic variceal
ligation (D’Amico 1999; Imperiale 2001; Gluud 2007). There-
fore, guidelines recommend endoscopy when cirrhosis is present
and at intervals thereafter in order to identify people at risk who
might benefit from prophylactic treatment. These guidelines re-
quire people to undergo an unpleasant invasive procedure with its
accompanying risks repeatedly, despite half of people having no
identifiable oesophageal varices 10 years after the initial diagnosis
of cirrhosis (Grace 1998; Jalan 2000; Adams 2004; Garcia-Tsao
2007; Garcia-Tsao 2008). Oesophago-gastro-duodenoscopy re-
quires appropriate sedation and analgesia (Cotton 2006), and is
associated with an overall complication rate of 0.13%, and a mor-
tality rate of 0.004% (Silvis 1976).
Two cost-effectiveness studies suggested avoidance of surveillance
oesophago-gastro-duodenoscopy and treatment with non-selec-
tive beta-blockers for all people with cirrhosis, irrespective of the
presence or size of varices (Saab 2003; Spiegel 2003). A third
cost-effectiveness analysis suggested that this non-selective strategy
should be reserved only for people with decompensated liver dis-
ease (Arguedas 2002). These conflicting cost-effectiveness recom-
mendations do not recognise that non-selective beta-blockers do
not prevent the development of oesophageal varices (Groszmann
2005). Therefore, oesophago-gastro-duodenoscopy remains the
recommended test for the diagnosis and prognosis of oesophageal
varices (Garcia-Tsao 2007; Garcia-Tsao 2008).
In view of the invasive nature and attendant cost of oesophago-
gastro-duodenoscopy, an accurate non-invasive test with adequate
accuracy could play a role as a screening test. Such a test will
assist in triaging people before oesophago-gastro-duodenoscopy
and, if varices of sufficient risk of bleeding are present, primary
prophylaxis will be recommended in order to prevent variceal
haemorrhage. Non-invasive tests for varices, if sufficiently accu-
rate in detecting high-risk varices, could even replace oesophago-
gastro-duodenoscopy, which is the preferred test for diagnosing
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oesophageal varices. This is why we aimed to assess the ability
of capsule endoscopy to triage people for oesophago-gastro-duo-
denoscopy investigation and in addition, if it could replace oe-
sophago-gastro-duodenoscopy.
O B J E C T I V E S
To determine the diagnostic accuracy of capsule endoscopy for
the diagnosis of oesophageal varices in children or adults with
chronic liver disease or portal vein thrombosis, irrespective of the
aetiology.To investigate the accuracy of capsule endoscopy as triage
or replacement of oesophago-gastro-duodenoscopy.
Secondary objectives
To determine the diagnostic accuracy of capsule endoscopy for
the diagnosis of medium oesophageal varices, large oesophageal
varices, and presence of red marks on the varices.
The following study characteristics, oesophageal varices, paediatric
compared to adult participants, chronic liver disease compared to
portal vein thrombosis, different stages of liver disease severity,
different aetiologies of liver disease (e.g., viral cirrhosis compared
with alcoholic cirrhosis; cholestatic compared to non-cholestatic
liver disease), prevalence of oesophageal varices in the study group,
and co-morbidities, were considered as sources of heterogeneity.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We aimed to include studies that, irrespective of publication sta-
tus and language, evaluated the diagnostic accuracy of capsule en-
doscopy for the diagnosis of oesophageal varices using oesophago-
gastro-duodenoscopy as the reference standard. We considered
cross-sectional cohort design studies on people with clinical sus-
picion of portal hypertension as well as participant-control de-
sign studies that compared people with oesophageal varices with
matched controls (Colli 2014).
We excluded studies in which data were analysed only per varix
rather than per participant unless the participant data were made
available by study authors.
Participants
Participants could be of any age in whom the presence of oe-
sophageal varices was clinically suspected (screening cohort) based
on chronic liver disease or portal vein thrombosis, irrespective of
the aetiology and duration of illness. We also considered people
with previous history of upper gastrointestinal bleeding or already
diagnosed oesophageal varices (surveillance cohort) for our review
as these participants are a distinct group in whom the presence of
oesophageal varices has a very higher probability than in a screen-
ing cohort, and when they participated in the studies, we analysed
their data separately.
We excluded studies with people with a previous surgical portal-
systemic shunt procedure or insertion of transjugular intrahepatic




The video capsule endoscope is a wireless capsule comprised of a
light source, lens, imaging hardware, battery, and a wireless trans-
mitter, designed to investigate the oesophagus. The capsule is swal-
lowed; it moves down the oesophagus via peristalsis. To improve
the oesophagus visualisation, the device can be modified by at-
taching a string to control movement up and down the oesoph-
agus (string capsule). The capsule obtains photographs at high
frequency that are transmitted to a recorder, worn on a belt. The
photographs are downloaded into a computer and can be viewed
individually or as a video.
There is a variety of classifications reported for oesophageal varices
observed with capsule endoscopy, with no current consensus. The
reported methods for evaluating the size of the oesophageal varices
with capsule endoscopy are frequently identical to oesophago-gas-
tro-duodenoscopy in spite of the lack of air inflation (which is not
possible with the capsule endoscopy). To standardise the classifica-
tion for the purposes of this review, oesophageal varices observed
with capsule endoscopy were dichotomised in the following way:
absence or presence of varices; and, small compared to medium
or large varices. A small varix is said to occupy less than 25%
and a medium/large varix to occupy more than 25% of the radius
of the lumen of the oesophagus. The description of red marks
on the varices follows the criteria used for oesophago-gastro-duo-
denoscopy: raised cherry-red spots (dilated sub-epithelial veins)
and red wale marking (longitudinal dilated veins resembling whip
marks).
Target conditions
The presence of any oesophageal varices (independent of size), de-
tected by oesophago-gastro-duodenoscopy. For secondary analy-
ses, the presence of medium or large varices (Garcia-Tsao 2007),
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and the presence of red marks were considered the target condi-
tions.
Reference standards
Oesophago-gastro-duodenoscopy is the reference standard test for
the diagnosis of oesophageal varices inwhich the presence of varices
in the oesophagus is directly observed by endoscopy. The size
and appearance of oesophageal varices is graded at the time of
endoscopy according to one of the following systems, using the
largest varix identified to classify the participant. People with an
indication for primary prophylactic therapy are considered to be
those whose largest varix is medium or large in size, or with small
varices with red marks.
1. The Baveno Consensus system differentiates small from
large oesophageal varices (de Franchis 1992). Small varices are
defined as varices that flatten with insufflation during endoscopy
or that minimally protrude into the oesophageal lumen. Large
oesophageal varices are defined as varices that protrude into the
oesophageal lumen and touch each other, or that fill at least 50%
of the oesophageal lumen.
2. The Japanese Research Society for Portal Hypertension
used three grades for variceal size (JSPH 1980). Grade 1 varices
collapse with insufflation during endoscopy, grade 2 do not
collapse with insufflation and do not occlude the lumen, and
grade 3 varices occlude the lumen. Grade 2 varices were
considered equivalent to medium, and grade 3 varices equivalent
to large for this review.
3. The Japanese classification was revised by the Italian Liver
Cirrhosis Project Group (Zoli 1996), which describes variceal
size as the percentage of the radius of the oesophageal lumen that
is occupied by the largest varix. A small or grade 1 varix is said to
occupy less than 25%, a medium or grade 2 varix to occupy 25%
to 50%, and a large or grade 3 varix to occupy greater than 50%
of the radius of the lumen of the oesophagus.
4. The Cales criteria define varices as small if they flatten with
insufflation during endoscopy, medium if they do not flatten
with insufflation, and large if they do not flatten with
insufflation during endoscopy and are confluent (Cales 1990).
We included studies applying other classifications if adequately
described and logically defined.
The presence of red marks is usually noted as present or absent
and may also be described according to different classifications.
Even small varices with the presence of red marks are classified as
’at high risk of bleeding’.
The interval between the index test and oesophago-gastro-duo-
denoscopy has to be less than 14 days in order to avoid possible
evolution of the target condition. In the case of longer time inter-
vals, we included the study but considered it at risk of bias.
Search methods for identification of studies
Electronic searches
We ran searches in The Cochrane Hepato-Biliary GroupDiagnos-
tic Test Accuracy Studies Register (October 2013), MEDLINE
(Ovid SP)(1950 to October 2013), EMBASE (Ovid SP) (1980
to October 2013), ACP Journal Club (Ovid SP) (1991 to Octo-
ber 2013), Database of Abstracts of Reviews of Effects (DARE)
(OvidSP) (third quarter), Health Technology Assessment (HTA)
(Ovid SP)(third quarter), NHS Economic Evaluation Database
(NHSEED) (Ovid SP) (third quarter), and ScienceCitation Index
Expanded (SCI-EXPANDED) (ISI Web of Knowledge) (1955 to
October 2013) (Royle 2003). We applied no language or docu-
ment type restrictions. We conducted the last search on 21 Octo-
ber 2013.
We used the multipurpose search command for the Ovid SP in-
terface (.mp.) and the topic search command for the ISI Web of
Knowledge interface (TS=) to search both text and database sub-
ject heading fields. To capture variations in suffix endings, the un-
limited truncation symbol ’*’ was used in both interfaces. Search
strategies with the time spans of the searches are listed in Appendix
1.
Searching other resources
We identified additional references by manually searching the ref-
erences of articles retrieved from the computerised databases and
relevant review articles. We contacted experts in the field for un-
published studies. In addition, we handsearched abstract books
from the American Association for the Study of Liver Diseases
meetings and European Association for the Study of the Liver
meetings from 2003 to 2013.
Data collection and analysis
We followed the available guidelines provided in the Cochrane
Handbook for Diagnostic Test Accuracy Reviews (DTA Handbook
2010).
Selection of studies
We retrieved publications if they were potentially eligible for in-
clusion based on abstract review. Two review authors (JCG or JY
and AC or GC) independently reviewed the publications for eligi-
bility. To be eligible, we assessed each publication to determine if
participants met the inclusion criteria. We only included abstracts
if sufficient data for 2 x 2 tables were provided for analysis. We
resolved any disagreements by consensus between JCG, JY, or AC
and GC.
Data extraction and management
Review authors, working in pairs (JCG and JY or AC and GC)
completed a data extraction form for each included study. AC and
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GC completed the extraction forms of the studies retrieved with
the last search (from 2009 to 2013). Each review author inde-
pendently retrieved the data: in case of discordance, we reached a
consensus through discussion.
We retrieved the following study data:
• general information: title, journal, year, publication status,
and study design;
• sample size: number of participants meeting the criteria and
total number screened;
• baseline characteristics: baseline diagnosis, age, sex, race,
disease severity, and concurrent medications used. Severity of
liver disease of the studied population may have been considered
using the Child-Pugh score (Pugh 1973), and model for end-
stage liver disease (MELD) scores in adults (Kamath 2001), and
by the Child-Pugh score and paediatric end-stage liver disease
(PELD) scores in children (McDiarmid 2002);
• the index test: type of capsule, number and experience of
readers, interobserver variation;
• reference standard test: variceal size, type of classification
used;
• prevalence of the target disease;
• number of true positive, true negative, false positive, and
false negative. These data were extracted for the two target
conditions;
• adverse events or complications due to the capsule
endoscopy.
We summarised data from each study in 2 x 2 tables (false positive,
false negative, true positive, true negative) according to the two
target conditions and to pre-defined sub-populations, and entered
into Review Manager 5 software (RevMan 2012).
Missing data
We contacted primary authors for missing data by e-mail. In ab-
sence of a reply, we sent a second e-mail two weeks later. We also
contacted one study author by telephone, but no supplementary
data were available (de Franchis 2008).
Assessment of methodological quality
Two review authors independently assessed the risk of bias of the
included studies using QUADAS-2 domains (Whiting 2011). A
third review author acted as arbitrator in case of disagreements
assessing the bias risk of the studies.
We adopted the domains in Appendix 2 to address aspects of
study quality involving the participant spectrum, index test, target
condition, reference standard, and flow and timing.We considered
studies classified as ’yes’ to be at low risk of bias. In the remaining
two cases of ’no’ or ’unclear’, we classified the studies as at high risk
of bias (Appendix 2).We removed the domain concerning the cut-
off values because we had planned to express the results of capsule
endoscopy as positive or negative (i.e., varices present or absent).
We added a further domain exploring the participant spectrum.
We considered a study at low risk of bias if only screening cohorts
were included, but at high risk of bias if surveillance cohorts were
also included and no separate analysis was available.
Statistical analysis and data synthesis
We presented data graphically using forest plots that show paired
sensitivities and specificities for each study, with the corresponding
95% confidence interval (CI). We also plotted data in the receiver
operating characteristic (ROC) space for a more thorough visual
assessment of the variation of test accuracy between studies.
Since all the studies were expected to use quite similar criteria
to define the presence of varices (i.e., the same implicit cut-off ),
we conducted the meta-analysis using the bivariate model, where
the logit transformed sensitivities and specificities were modelled
(Reitsma 2005). If the model did not converge, we fitted the hier-
archical summary ROC (HSROC) model. For each analysis, we
calculated the summary sensitivity and specificity (summary oper-
ating point) with their 95% CIs starting from parameter estimates
obtained from the bivariate or HSROC models (Reitsma 2005).
We calculated positive (LR+) and negative (LR-) likelihood ratios
from summary sensitivity and specificity.We assessed the presence
of a possible implicit threshold effect through visual inspection of
the plot of the studies in the ROC space.
We performed all analyses using statistical software SAS (release
9.2) and macro METADAS (DTA Handbook 2010).
Investigations of heterogeneity
We investigated heterogeneity first by visual inspection of the
paired forest plots of sensitivities and specificities. Subsequently,
we performed a subgroup analysis, where appropriate, consider-
ing some possible sources of heterogeneity. As possible sources of
heterogeneity, we considered the criteria to diagnose and charac-
terise oesophageal varices; paediatric compared to adult partici-
pants; chronic liver disease compared to portal vein thrombosis;
severity of liver disease; different aetiologies of liver disease (e.g.,
viral cirrhosis compared to alcoholic cirrhosis; cholestatic com-
pared to non-cholestatic liver disease); prevalence of oesophageal
varices in the study (higher than 50% compared to lower than
50%); co-morbidities, and type of video capsule (standard com-
pared to string capsule).
Sensitivity analyses
In order to assess the robustness of the results, we undertook several
sensitivity analyses to explore the effect of studies at high risk of
bias on overall results.
To account for the possible bias introduced by studies with risk of
bias, we had planned some sensitivity analyses:
• considering only the studies that were published in full text;
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• considering only the studies classified at low risk of bias for
each domain of QUADAS-2;
• considering only cross-sectional design studies.
R E S U L T S
Results of the search
We identified 1836 references through electronic searches of the
Cochrane Hepato-Biliary Group Controlled Trial Register (N =
1), The Cochrane Library (N = 155), MEDLINE (Ovid SP) (N =
415), EMBASE (Ovid SP) (N = 869), and Science Citation Index
Expanded (N = 396). After the exclusion of 587 duplicates, 1249
references remained; we found 1226 to be irrelevant references.
Twenty-three references on studies seemed to fulfil the inclusion
criteria. We excluded seven studies after reading the full text. Fi-
nally, we included 16 studies and considered them for data anal-
yses (Figure 1).
Figure 1. Results of the studies search
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We included 16 studies in this review, of which 11 evaluated the
PillCam ESO (Given Imaging, Israel), two did not specify which
device was used (Groce 2007; Frenette 2008), two assessed string
capsule in which an M2A capsule endoscope (Given Imaging,
Israel) was moved up and down the oesophagus using a string
attached to the capsule (Ramirez 2005; Stipho 2012), and one
assessed PillCam SB/SB2, a device designed for investigation of
the small intestine and not dedicated to the oesophagus (Aoyama
2014). One study assessed the accuracy of capsule endoscopy for
the diagnosis of large (high-risk) oesophageal varices (Frenette
2008). The remaining 15 studies assessed the accuracy for the di-
agnosis of varices of any size. All studies were undertaken in a
secondary or tertiary care setting. All studies included only adults
with cirrhosis. One study also included people with portal throm-
bosis (66/288 participants) combining the participant data all to-
gether for analysis (de Franchis 2008). We requested data for a
separate analysis from the corresponding author, but obtained no
further information. Four of the studies were reported in abstract
form only (Donnelly 2006; Groce 2007; Gerson 2008; Sharma
2009).
All studies were designed as cross-sectional cohort studies. Seven
studies included only people with the suspected, but unknown,
presence of oesophageal varices (screening cohort) (Lapalus
2006; Groce 2007; Gerson 2008; Lapalus 2009; Sharma 2009;
Chavalitdhamrong 2012; Aoyama 2014). This participant sam-
pling was considered as the most appropriate to assess the accuracy
of the index test. In the other nine studies, people with antecedent
diagnosis of oesophageal varices were also enrolled (surveillance
cohort) and the participant data were combined for analysis, likely
introducing a selection bias. We requested data for a separate anal-
ysis from the corresponding author, but no further information
was obtained. Seven studies presented further analyses considering
the use of capsule endoscopy to diagnose large oesophageal varices
(Summary of findings) with or without the presence of red marks;
one study assessed only accuracy of capsule endoscopy for the de-
tection of high-risk varices (large varices or small varices with red
marks) (Frenette 2008).
Methodological quality of included studies
The evaluation of methodological quality is presented in Figure
2 and Figure 3. We evaluated studies according to QUADAS-2
domains. Two areas were poorly reported by many studies. First,
reporting of participant recruitment frequently left some uncer-
tainty about whether those included participants were a represen-
tative spectrum of participants in whom the non-invasive diagno-
sis of varices might be appropriately considered in clinical prac-
tice. In fact, even in the studies that included only people with
suspected oesophageal varices, the prevalence of the target disease
was higher (median 63%; range 43% to 82%) than expected in
early cirrhosis (Merli 2003). Large cohort studies reported a lower
prevalence of oesophageal varices at the time of diagnosis of cir-
rhosis, of around 50% (Garcia-Tsao 2008). One study included
only people on the waiting list for orthotopic liver transplantation,
and thus, it included people with more advanced disease than in
other studies (Gerson 2008). Another study enrolled only people
defined as affected by end-stage liver disease without any other
specification, and found a high prevalence of oesophageal varices
(82%); we classified this study as a high-risk study as the partici-
pants and the setting did not match the review question (Sharma
2009).
Figure 2. Methodological quality of the 10 included studies.
9Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 3. Quality assessment summary: review authors’ judgements about each risk of bias item for each
included study.
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Nine studies included and analysed together either people with
suspected target disease (screening cohort) or people with an-
tecedent diagnosis of oesophageal varices (surveillance cohort).We
requested data for separate analysis from the corresponding au-
thors, but received no answers. The inclusion of a different mix-
ture of people with suspected or known varices introduces a spec-
trum bias that could impair the estimation of diagnostic accuracy
in the detection of any size varices. In these studies, the prevalence
of oesophageal varices was higher (range 63% to 95%) than that
reported in studies that include only a screening cohort.
Data on uninterpretable results of the index test were not always
reported and were excluded from the final analysis, thus prevent-
ing an ’intention-to-diagnose’ analysis. Capsule endoscopy is not
always easy for people to swallow and does not always produce
adequate images of the oesophagus; these uninterpretable results
should be taken into account when estimating the diagnostic ac-
curacy of capsule endoscopy.
Due to the required design characteristics of the studies to be in-
cluded in this review, we did not expect to find any studies with
weakness in the choice of reference standard, partial or differential
verification bias, or incorporation bias. None of the studies showed
flaws concerning these criteria and only one study reported an un-
acceptable delay between the index and the reference standard test
(Stipho 2012). In all the studies, the interpretation of the capsule
endoscopy results were blinded to the results of the reference test,
but it was not always stated whether the reference standard (oe-
sophago-gastro-duodenoscopy) results were interpreted without
knowing the capsule endoscopy results. One study performed en-
doscopy immediately after capsule endoscopy, thus preventing the
availability of capsule endoscopy information when interpreting
the oesophago-gastro-duodenoscopy results (Schreibman 2011).
Other studies did not explicitly state this blinding (Ramirez 2005;
Gerson 2008; Lapalus 2009; Aoyama 2014), and we interpreted
this lack as a reporting flaw that would probably not introduce
bias.
Studies did not always report a plan to collect data on adverse
events associated with the capsule endoscopy, and such events were
only occasionally reported. Finally, only three studies provided in-
terobserver agreement in index test interpretation (Frenette 2008;
Gerson 2008; Lapalus 2009).
Findings
Diagnosis of any oesophageal varices
All the studies
Fifteen of the 16 included studies with 936 participants reported
accuracy estimates data on the ability of capsule endoscopy to
detect varices of any size. Among the 936 included participants,
640 (68.4%) had varices of any size (median 72%; range 43% to
95%).
In 13 studies that provided at least some details of the cause of
portal hypertension, people with parenchymal liver disease only
were included in 11 studies. In one study, the proportion of peo-
ple with non-cirrhotic causes of portal hypertension (e.g., portal
vein thrombosis or Budd-Chiari syndrome) was less than 23%
(de Franchis 2008), and other two studies reported no details
(Eisen 2006; Sharma 2009). Specific diseases reflected the com-
mon causes of cirrhosis in adults, particularly hepatitis C, alco-
holic liver disease, and non-alcoholic fatty liver disease. Four stud-
ies did not report any details about the severity of the liver cirrho-
sis (Child-Pugh classification or MELD score) (Donnelly 2006;
Eisen 2006; Groce 2007; Sharma 2009). In one study of 24 par-
ticipants, the majority (71%) were Child-Pugh score B (Gerson
2008). In the other 10 studies that provided some details of Child-
Pugh score, people with compensated cirrhosis were the largest
group, but a variable proportion of people with decompensated
cirrhosis (class B and C) were also included.
The sensitivity of capsule endoscopy to diagnose oesophageal
varices of any size ranged from 65% to 100%, and the specificity
from 33% to 100% (Figure 4). The visual inspection of the plot
of the studies’ results in the ROC space suggested the same im-
plicit cut-off, as the disposition of the study points in the ROC
plot (Figure 5) was not consistent with the presence of a threshold
effect (i.e., there was not a clear negative correlation between sen-
sitivity and specificity). The bivariate model was fitted and a sum-
mary operating point (mean sensitivity and mean specificity) was
estimated. The pooled estimates of sensitivity and specificity were
84.8% (95% CI 77.3% to 90.2%) and 84.3% (95% CI 73.1% to
91.4%). The LR+ was 5.4 (95% CI 3.1 to 9.5) and the LR- was
0.18 (95% CI 0.12 to 0.27) (Figure 4; Figure 5).
11Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 4. Forest plot: Diagnosis of any varices - all the studies.
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Figure 5. Studies in the receiver operating characteristic (ROC) space: Diagnosis of any varices - all the
studies
Using themedian prevalence of oesophageal varices in the 15 stud-
ies (72%) as a pre-test probability, we obtained a post-test proba-
bility of 93% if the test was positive, and a post-test probability of
32% if the test was negative. The prevalence of oesophageal varices
of any size in the seven studies at low risk of bias according to the
QUADAS-2 ’participants selection’ domain was 63% (see ’sensi-
tivity analysis’ below). Using this value as a pre-test probability,
we obtained a post-test probability of 90% if the test was positive,
and a post-test probability of 23% if the test was negative.
Subgroup analyses
In the 13 studies (806 participants) that used the ESO standard
capsule, the pooled estimate of sensitivity was 83.9% (95% CI
75.3% to 90.0%) and the pooled estimate of specificity was 84.5%
(95% CI 71.8% to 92.1%); otherwise in the other two studies
with 130 participants that used a modified device (i.e., the string
capsule), sensitivity was 90.0% (95% CI 72.4% to 96.9%) and
specificity was 86.9% (95%CI 30.7% to 99.0%) (Figure 6; Figure
7). No other planned subgroup analysis was possible. In particu-
lar, criteria to diagnose and characterise oesophageal varices were
13Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
similar among the included studies; no study included children,
and people with portal vein thrombosis were included in only one
study (de Franchis 2008), but these participants were not analysed
separately. No data on co-morbidities were available in any study.
Finally, the prevalence of varices was lower than the expected value
of 50% in only two studies, both still available in abstract form
(Groce 2007; Gerson 2008).
Figure 6. Forest plot: Diagnosis of any varices - all the studies.
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Figure 7. Studies in the receiver operating characteristic (ROC) space: Diagnosis of any varices - all the
studies.
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Sensitivity analyses
We performed a sensitivity analysis considering only the seven
studies with 396 participants at low risk of bias for the QUADAS-
2 ’participant selection’ domain (studies that included only screen-
ing cohorts of participants). This showed a pooled sensitivity of
79.7% (95% CI 73.1% to 85.0%), a specificity of 86.1% (95%
CI 64.5% to 95.5%), an LR+ of 5.8 (95% CI 2.1 to 16.1) and a
LR- of 0.24 (95% CI 0.18 to 0.31) (Figure 8; Figure 9). Using the
prevalence of oesophageal varices of any size in these seven studies
(63%) as a pre-test probability, we obtained a post-test probability
of 91% if the test was positive, and a post-test probability of 29%
if the test was negative.
Figure 8. Forest plot: Diagnosis of any varices - studies at low risk of bias for QUADAS-2 ’patient selection’
domain.
16Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 9. Studies in the receiver operating characteristic (ROC) space: Diagnosis of any varices - studies at
low risk of bias for QUADAS-2 ’patient selection’ domain.
We performed a second sensitivity analysis considering the nine
studies with 687 participants at low risk of bias for the QUADAS-
2 ’flow and timing’ domain. This showed a pooled sensitivity of
85.8% (95% CI 75.5% to 92.2%) and specificity of 82.5% (95%
CI 62.2% to 93.1%) (Figure 10; Figure 11).
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Figure 10. Forest plot: Diagnosis of any varices - studies at low risk of bias for QUADAS-2 ’flow and timing’
domain.
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Figure 11. Studies in the receiver operating characteristic (ROC) space: Diagnosis of any varices - studies at
low risk of bias for QUADAS-2 ’flow and timing’ domain.
Finally, when considering the 11 studies with 849 participants
alone that were published as full-text articles, the pooled sensitivity
was 82.6% (95% CI 75.4% to 88.0%) and the pooled specificity
was 88.0% (95% CI 73.9% to 95.0%). LR+ was 6.9 (95% CI
3.0 to 16.0) and LR- was 0.20 (95% CI 0.14 to 0.29) (Figure 12;
Figure 13).
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Figure 12. Forest plot: Diagnosis of any varices - only full-text studies.
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Figure 13. Studies in the receiver operating characteristic (ROC) space: Diagnosis of any varices - only full-
text studies.
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Diagnosis of medium/large oesophageal varices
Six studies with 537 participants assessed the accuracy of cap-
sule endoscopy for the diagnosis of large oesophageal varices
(de Franchis 2008; Frenette 2008; Lapalus 2009; Sharma 2009;
Schreibman 2011; Ishiguro 2012). Pooled sensitivity was 73.7%
(95% CI 52.4% to 87.7%), pooled specificity was 90.5% (95%
CI 84.1% to 94.4%), LR+ was 7.7 (95% CI 4.2 to 14.2) and
LR- was 0.29 (95% CI 0.14 to 0.58) (Figure 14; Figure 15). The
prevalence of large oesophageal varices in the six studies was 37%.
Using this value as a pre-test probability, we obtained a post-test
probability of 82% if the test was positive, and a post-test proba-
bility of 15% if the test was negative.
Figure 14. Forest plot: Diagnosis of medium/large varices - all the studies.
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Figure 15. Studies in the receiver operating characteristic (ROC) space: Diagnosis of medium/large varices
- all the studies.
Diagnosis of red marks
Three studies with 150 participants assessed the accuracy of cap-
sule endoscopy for the presence of red marks (Chavalitdhamrong
2012; Ishiguro 2012; Stipho 2012). The statistical model did not
converge and, as a consequence, it was not possible to provide a
pooled estimate of sensitivity and specificity.We found a large vari-
ation of sensitivity (47% to 94%) and specificity (60% to 89%)
among the three studies (Figure 16; Figure 17).
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Figure 16. Forest plot: Diagnosis of red marks - all the studies.
Figure 17. Studies in the receiver operating characteristic (ROC) space: Diagnosis of red marks - all the
studies.
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Interobserver agreement
Four studies reported interobserver agreement of capsule en-
doscopy interpretation (Frenette 2008; Gerson 2008; Lapalus
2009; Chavalitdhamrong 2012). In the study by Gerson 2008,
published in abstract form only, the kappa coefficient for agree-
ment between two observers was 0.55 (95% CI 0.31 to 0.79)
for the presence of any oesophageal varices, and 0.70 (95% CI
0.31 to 1.0) for the grading of varices. Frenette 2008 reported
both interobserver and intraobserver agreement for detection of
high-risk varices: kappa = 0.56 and kappa = 0.61 for reader 1 and
kappa = 0.41 for reader 2. Lapalus 2009 reported a concordance
of 79.4% between observers in the diagnosis of any oesophageal
varices (kappa = 0.58), 66.4% for the grading of varices (kappa =
0.79), and 89.7% for the identification of large varices (kappa =
0.32). Chavalitdhamrong 2012 reported an interobserver agree-
ment of kappa = 0.778 ± 0.085 for the detection of any size varices.
Adverse events
In 10 studies, participants reported some minor discomfort on
swallowing the capsule (Ramirez 2005; Eisen 2006; Lapalus 2006;
Groce 2007; de Franchis 2008; Frenette 2008; Gerson 2008; Pena
2008; Chavalitdhamrong 2012; Stipho 2012). Only one study
identified other significant adverse events, including impaction of
the capsule due to a previously unidentified oesophageal stricture
in two participants (de Franchis 2008). It is interesting to note
that this study excluded people with possible oesophageal steno-
sis or other pathologies that could impair passage of the capsule
endoscopy through the oesophagus.
No adverse events were reported as a consequence of the reference
standard oesophago-gastro-duodenoscopy.
Participants’ preferences
Ten studies planned explicitly to test participants’ preferences
(Ramirez 2005; Eisen 2006; Lapalus 2006; Groce 2007; de
Franchis 2008; Frenette 2008; Gerson 2008; Pena 2008;
Chavalitdhamrong 2012; Stipho 2012). Nine studies, using dif-
ferent methodology, reported a preference for capsule endoscopy
over oesophago-gastro-duodenoscopy, and one study found no
preferences (Pena 2008).
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Summary of findings
Population: adults with chronic liver disease with no previous gastrointestinal haemorrhage. There were no children or people with portal vein thrombosis in the included studies
Index test: capsule endoscopy (PillCam ESO, Given Imaging, Israel); 2 studies used string wireless capsule endoscopy (M2A Capsule, Given Imaging, Israel). 2 studies did not specify which
device was used (Groce 2007; Frenette 2008), and 1 study used PillCam SB/SB2 a device planned for intestinal exploration not dedicated to the oesophagus (Aoyama 2014).
Target condition: presence of any oesophageal varices or the presence of medium/large oesophageal varices
Reference standard: oesophago-gastro-duodenoscopy.
Studies included: 16 studies.
15 studies considered ‘ ‘ any oesophageal varices’’ as target disease, while 1 study considered only ‘ ‘ large oesophageal varices.’’
Overall, for 6 studies data were available for the target condition ‘ ‘ large oesophageal varices.’’
All the studies were prospectively cross-sectional designed.
Pooled estimates
(95% CI)
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CI: confidence interval; LR-: negative likelihood ratio; LR+: positive likelihood ratio; n: number of participants; N: number of studies.
1Two scenarios were considered: median prevalence of the seven studies at low risk of bias according to QUADAS2 item ’Patients
selection’ (63%); median prevalence of all the 15 studies (72%).
2Only one scenario with specific group prevalence was considered.









































































































































D I S C U S S I O N
Summary of main results
In this review, we aimed to determine the diagnostic accuracy
of capsule endoscopy for the diagnosis of oesophageal varices in
adults or children with chronic liver disease or portal vein throm-
bosis, when compared to the reference standard test, oesophago-
gastro-duodenoscopy. All of the 16 studies included in the review
were undertaken in adults in a secondary care setting, with a 63%
median prevalence of varices.
There are two main indications for oesophago-gastro-duo-
denoscopy in people with cirrhosis, apart from themanagement of
acute gastrointestinal bleeding: screening for oesophageal varices
when the diagnosis of cirrhosis, and surveillance of people with
known varices and antecedent variceal bleeding or treatment (e.g.,
endoscopic variceal ligation), or both. In this review, seven stud-
ies included only a screening cohort: summary statistics obtained
from these studies showed that capsule endoscopy has a low sensi-
tivity leaving more than 20% of varices undetected. Furthermore,
about 15% of positive capsule endoscopy results were not con-
firmed at endoscopy. In these studies, the prevalence of varices
ranged from 43% to 82%, and the estimates of accuracy can be
considered at low risk of bias for participant selection. Hence, the
heterogeneity in the results of these studies arises from sources
other than different inclusion criteria. A difference in index test
positivity criteria for the definition of the presence of oesophageal
varices (implicit cut-off ) might play a role. In fact, as shown in
Figure 9, the seven studies distribute along the horizontal axis
showing a wide specificity variation with an almost fixed sensitiv-
ity value, suggesting that differences of an implicit cut-off could
only impair the index test specificity without any improvement
of the sensitivity. Therefore, it seems unlikely that the sensitivity
of capsule endoscopy could be improved enough for it to fulfil its
possible role as a screening test before endoscopy adequately.
Eight studies included a mixed population of people with sus-
pected (screening cohorts) and knownoesophageal varices (surveil-
lance cohorts). In these studies, the target disease prevalence varied
(from 63% to 95%) according to the different proportion of mix-
ing. We considered this mixed participant selection to be at high
risk of bias, increasing the proportion of people with the target
disease and therefore potentially overestimating the accuracy of
the index test. Unfortunately, we were unable to obtain data from
the authors of these studies to allow separate analysis of the two
participant groups. The pooled estimate of sensitivity was 82.2%
(95% CI 76.4% to 86.7%) and of specificity was 85.7% (95% CI
80% to 90%) for these studies.
To investigatewhether capsule endoscopy can identify oesophageal
varices at high risk of bleeding and thus requiring primary prophy-
laxis, some studies determined the diagnostic accuracy of capsule
endoscopy for large varices. In the six studies that evaluated the ac-
curacy of capsule endoscopy in detecting large varices, the pooled
sensitivity was 73.7% (95% CI 52.4% to 87.7%) and specificity
was 90.5% (95% CI 84.1% to 94.4%). As shown in Figure 15, a
wide variation of the sensitivity was observed with only minimal
variations of the specificity. An interpretation might be that any
variation of the intrinsic cut-off in the interpretation of capsule
endoscopy results could produce wide variation of the sensitivity
without changes of the specificity.
Redmarks on varices are another criterionof high risk for bleeding,
including when associated with small varices that would then be
considered for primary prophylactic therapy. Only three studies
assessed the role of capsule endoscopy in detecting red marks on
varices, showing very wide variations of the estimates of sensitivity
and specificity.
Interobserver agreement in the interpretation of capsule en-
doscopy results and any adverse event attributable to capsule en-
doscopy were poorly assessed and reported. Participants’ pref-
erences for either capsule endoscopy or oesophago-gastro-duo-
denoscopy were differently evaluated and reported but seemed in
favour of capsule endoscopy.
Strengths and weaknesses of the review
Despite an extensive and thorough search, we retrieved only 16
studies with small sample sizes, of which nine were assessed with
high risk of bias due to sub-optimal study design. Most studies
assessed whether capsule endoscopy detected the presence of any
varices, although themain clinical reason to screen for oesophageal
varices is to identify people who are at high risk of bleeding and
who may, therefore, benefit from primary prophylactic therapy.
Only six studies assessed the accuracy of capsule endoscopy in de-
tecting large varices. The risk of bleeding was not directly mea-
sured but instead it was implied from knowledge that larger varices
and those with red marks identified by oesophago-gastro-duo-
denoscopy were more likely to bleed. There is currently no agreed
system for reporting the appearance of varices identified by capsule
endoscopy. The role of capsule endoscopy in identifying the risk of
bleeding has not been studied and may differ from oesophago-gas-
tro-duodenoscopy because there is no ability to examine changes
in varices during insufflation of air.
Only six studies reported the proportion of non-evaluable results
of the index test and it is not always clear whether this means
that no uninterpretable results were observed in the other stud-
ies (Lapalus 2006; de Franchis 2008; Gerson 2008; Pena 2008;
Chavalitdhamrong 2012; Aoyama 2014). No studies undertook
analysis according to ’intention to diagnose’. In the studies that
reported uninterpretable results, study participants with uninter-
pretable results were excluded from the analyses, possibly causing
a consequent overestimation of diagnostic accuracy.
Only four studies assessed the interobserver agreement of capsule
endoscopy and reported it as moderate or less than moderate.
Another relevant point is that the oesophago-gastro-duo-
denoscopy reference standard is not perfectly accurate and repro-
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ducible (Cales 1989; Bendtsen 1990; Winkfield 2003), impairing
a true estimate of the index test accuracy.
The pooled sample is inadequate to explore possible rare adverse
events; capsule impaction was observed in two participants from
the same study in which oesophageal stenosis and other possi-
ble causes of obstruction were among the exclusion criteria (de
Franchis 2008).
No studies have yet adequately investigated the use of capsule
endoscopy for the diagnosis of oesophageal varices due to portal
vein thrombosis or in children. Studies have not investigated any
differences in the accuracy of capsule endoscopy for the diagnosis
of oesophageal varices in people with different hepatic causes of
portal hypertension.
We found only two meta-analyses about this topic (Lu 2009;
Guturu 2011). They included seven and nine studies, and the
accuracy estimates were similar to the ones we obtained. In both
studies, authors concluded that more studies were needed to assess
the capsule endoscopy accuracy better. We also retrieved some
narrative reviews that also highlighted the need formore data (Ruff
2009; Rondonotti 2010). Finally, a study by White 2009 tried a
decision analysis to show that capsule endoscopy was more cost
effective thanoesophago-gastro-duodenoscopy for the screening of
oesophageal varices in people with cirrhosis, even if the differences
in cost and effectiveness were small. However, no systematic review
of studies was reported, making it difficult to assess the validity of
clinical estimates objectively.
Applicability of findings to the review question
The accuracy of capsule endoscopy in detecting the presence of
oesophageal varices has been, with the above noted limitations,
addressed only in secondary or tertiary care settings and in adults
with suspected cirrhosis mainly due to chronic viral hepatitis or
alcoholic liver disease. We observed wide variation of the preva-
lence of the target condition even in studies at low risk of bias
for participant selection. The applicability to other specific partic-
ipant groups, such as those with cholestatic diseases, portal vein
thrombosis, or children with liver disease, or in other settings with
lower prevalence of the target condition is even more uncertain.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Although current guidelines recommend oesophago-gastro-duo-
denoscopy to screen for varices in all adults with suspected cirrho-
sis, there has been poor uptake of this recommendation because
oesophago-gastro-duodenoscopy is invasive, unpleasant, and has
a low diagnostic yield when applied to all adults with cirrhosis.
Therefore, there is a pressing need for a non-invasive test that en-
ables oesophago-gastro-duodenoscopy to be applied to a higher
risk patient group. This review shows that capsule endoscopy is
more acceptable to patients, but it is not sufficiently accurate to
replace endoscopy for the detection of oesophageal varices. Fur-
thermore, its sensitivity does not seem able to support a triage test
role before endoscopy in order to spare the number of oesophago-
gastro-duodenoscopy examinations.
Implications for research
Larger cross-sectional studies are needed for a more precise esti-
mation of sensitivity and specificity. An agreed system for describ-
ing and reporting the appearance of varices identified by capsule
endoscopy would support studies that evaluate the role of capsule
endoscopy in assessing the risk of variceal bleeding and comparing
it with endoscopy for the prediction of bleeding. We totally lack
data in paediatric populations and in people with portal throm-
bosis.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Aoyama 2014
Study characteristics
Patient sampling Cross-sectional cohort (only screening cohort); prospective single-centre study
Patient characteristics and set-
ting
Participants: 119 participants; 73 men, 46 women; mean age 66.9 years, range 23 to 88 years
Baseline diagnosis: clinically or histologically confirmed cirrhosis. Aetiology: 18 HBV; 70 HCV;
13 alcohol; 6 non-alcoholic steatohepatitis; 12 other
Disease severity: 56 participants were Child-Pugh score A, 56 participants were Child-Pugh score
B, and 7 participants were Child-Pugh score C
Co-morbidity: not available.
Geographic location of the study: Japan.
Inclusion criteria: clinically or histologically confirmed cirrhosis with suspected bleeding from the
small bowel or iron deficiency anaemia with a haemoglobin level of ≤ 12.0 g/dL, or both
Exclusion criteria: people with previous treatment for portal hypertension; previous bleeding
Index tests Index test: PillCam SB/SB2 video capsule (Given Imaging Ltd, Yokneam, Israel) a device planned
for intestinal exploration not dedicated to the oesophagus
Criteria for oesophageal varices: oesophageal varices appearing as abnormally dilated longitudinal
veins in the oesophagus
Operator: 2 interpreters, who were unaware of the participants’ oesophago-gastro-duodenoscopy
results, evaluated the images captured by capsule endoscopy for the presence or absence of oe-
sophageal varices. Diagnoses were reached by consensus. The 2 interpreters had limited experience
with oesophageal capsule endoscopy but much experience with capsule endoscopy (> 200 small-
bowel examinations) and oesophago-gastro-duodenoscopy (> 3000 examinations)
Target condition and reference
standard(s)
Target condition: presence of any oesophageal varices.
Reference standard: oesophago-gastro-duodenoscopy.
Criteria for oesophageal varices: the Japanese endoscopic classification (JSPH 1980).
Prevalence of the target condition: 43% (51/119).
Flow and timing
Comparative
Notes Observer variation: no data on observer variation were reported.
Uninterpretable results: no data on withdrawals were reported.
Side effects or complications: no side effects or complications were described.
Type of publication: full text.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Aoyama 2014 (Continued)
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Did the study enrol only
patients with suspected oe-




DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of




DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Patient sampling Cross-sectional cohort (only screening cohort); prospective single-centre study
Patient characteristics and set-
ting
Participants: 65 participants 43 (66.2%) men and 22 (33.8%) women. Mean age 54.6 years (range
35 to 79 years)
Baseline diagnosis: liver disease. Aetiology: 37 HCV infection, 13 alcoholic liver disease, 5 chronic
HBV infection, 4 non-alcoholic steatohepatitis, 3 autoimmune liver disease, 3 primary biliary
cirrhosis
Disease severity: 27 participants were Child-Pugh score A, 27 participants were Child-Pugh score
B, 11 participants were Child-Pugh score C. Mean MELD score of 10.6 and a mean Child-Pugh
score of 7.4
Co-morbidity: not available.
Geographic location of the study: USA.
Inclusion criteria: 1. aged ≥ 18 years and < 86 years at the time of consent; 2. clinically evident or
biopsy-confirmed cirrhosis; 3. no previous documented upper gastrointestinal bleeding; 4. no previ-
ous endoscopic or radiological treatments for variceal bleeding or ascites; 5. probable life expectancy
of ≥ 24 months without liver transplantation and have a MELD score of ≤ 29. Oesophago-gas-
tro-duodenoscopy was scheduled for these participants assuming that they required screening and
potentially treatment
Exclusion criteria: 1. severe co-morbid illness; 2. cancer with less than a 24-month expected
survival or cancer on active treatment with chemotherapy or radiotherapy, or a combination; 3.
oesophagealmotility disorder, oesophageal stricture, or oesophageal diverticulum, causing dysphagia
or requiring dilation; 4. gastrointestinal obstruction or partial obstruction (by history or imaging); 5.
symptomatic gastrointestinal stricture or pseudo-obstruction thatmay prevent passage of the capsule;
or 6. potentially reversible portal hypertension such as alcoholic hepatitis, acute viral hepatitis,
untreated autoimmune hepatitis or chronic HBV or HCV on viral therapy
Index tests Index test: capsule endoscopy (PillCam ESO, Given Imaging, Ltd, Yoqneam, Israel)
Criteria for oesophageal varices: modified Japanese grading system (none, no varices seen; small,
the oesophageal varices were small and non-tortuous and not compromising the lumen; medium,
the oesophageal varices were tortuous, raised and occupied less than one-third of the distal oe-
sophageal lumen; large, oesophageal varices were large, raised, tortuous, compromising the lumen,
and occupied more than one-third of the distal oesophagus)
Operator: coded capsule images were read by 2 experienced oesophageal capsule endoscopy physi-
cians, blinded to oesophago-gastro-duodenoscopy findings
Target condition and reference
standard(s)
Target condition: presence of any oesophageal varices and red marks.
Reference standard: oesophago-gastro-duodenoscopy.
Criteria for oesophageal varices: standard grading for oesophageal varice was used.
Prevalence of the target condition: 71% (46/65).
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Chavalitdhamrong 2012 (Continued)
Flow and timing Completeness of analysis: 9 participants not included in the analysis. Reasons for not being
included in the study were as follows: 2 participants refused to swallow the capsule; 3 participants
refused to participate in the oesophageal capsule endoscopy study; 1 participant vomited the capsule
out after swallowing it (but had no stricture on oesophago-gastro-duodenoscopy); 3 participants
swallowed the capsule but images were not recorded. These 9 participants had oesophago-gastro-
duodenoscopy screening, but were not included in this comparative study
Comparative
Notes Observer variation: no data on observer variation were reported.
Uninterpretable results: data were reported.
Side effects or complications: no side effects or complications were described.
Type of publication: full text.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Did the study enrol only
patients with suspected oe-




DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of




DOMAIN 3: Reference Standard
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Chavalitdhamrong 2012 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Patient sampling Cross-sectional cohort study (screening cohort + surveillance cohort). Prospective,multicentre study
with 11 centres
Patient characteristics and set-
ting
Participants: 288 participants (screening cohort: 195 participants; surveillance cohort: 93 partici-
pants); mean 56 years, range 21 to 81 years. Sex: not available
Baseline diagnosis: cirrhosis. Aetiology: 20% alcohol, 8.9% HBV, 35.0% HCV, 13.3% alcohol +
HBV or HCV cirrhosis, 22.8% other (Budd-Chiari syndrome, portal vein thrombosis, etc.)
Disease severity: Child-Pugh score A 68.8%; Child-Pugh score B 25.4%; Child-Pugh score C 5.
8%
Co-morbidity: not available.
Geographical location of the study: Italy, Spain, USA, and Israel.
Inclusion criteria: ≥ aged 18 years. Signs/symptoms of portal hypertension, without previous
diagnosis of oesophageal varices, with clinical indication for screening endoscopy for the detection
of varices, or with prior endoscopic diagnosis of oesophageal varices and indication for surveillance
endoscopy
Exclusion criteria: dysphagia, Zenker’s diverticulum, previous endoscopic treatment of oesophageal
varices, known or suspected intestinal obstruction, cardiac pacemakers or other implanted electro-
medical devices, pregnancy, planned magnetic resonance imaging examination within 7 days after
ingestion of the capsule, prior abdominal surgery of the gastrointestinal tract (other than uncompli-
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cated appendectomy or uncomplicated cholecystectomy), any condition that precluded compliance
with study or device instructions (or both), life-threatening conditions and current participation in
another clinical study
Index tests Index test: capsule endoscopy (PillCam ESO, Given Imaging, Ltd., Yoqneam, Israel)
Criteria for oesophageal varices: small varices occupying < 25% of the circumference and large
varices occupying > 25%
Operator: experienced capsule endoscopist, blinded from the reference standard
Target condition and reference
standard(s)
Target condition: any oesophageal and large oesophageal varices.
Reference standard: oesophago-gastro-duodenoscopy.
Criteria for oesophageal varices: other classification, adequately described and logically defined
Prevalence of the target condition: 63% (180/288 participants). 79 with large oesophageal varices
Flow and timing 2 participants were withdrawn from the study. 1 due to “loss of capsule endoscopy recording” and
1 for unsuspected oesophageal stricture
Comparative
Notes Observer variation: no data on observer variation reported.
Uninterpretable results: data were reported.
Side effects or complications: side effects or complications: overall, 4 (1.4%) adverse events were
reported within the study. 1 episode of severe pain occurred with oesophago-gastro-duodenoscopy
and improved within 1 week. 3 adverse events occurred with the capsule: 1 episode of diarrhoea that
resolved spontaneously within 24 hours, 1 episode of nausea with capsule retention due to an unsus-
pected oesophageal stricture requiring removal of the capsule by oesophago-gastro-duodenoscopy,
and 1 episode of vomiting caused by capsule retention due to an unsuspected oesophageal stricture
(the capsule was passed by mouth by vomiting)
Type of publication: full text.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Did the study enrol only
patients with suspected oe-
sophageal varices not until di-
agnosed?
No
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Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of




DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Patient sampling Cross-sectional cohort study (screening cohort + surveillance cohort). Prospective, single-centre
study
Patient characteristics and set-
ting
Participants: 8 participants (screening cohort: 4 participants; surveillance cohort: 4 participants);
5 males and 3 females; age not reported
Baseline diagnosis: aetiology: 5 alcohol, 1 HCV, 1 non-alcoholic fatty liver disease, 1 primary
sclerosing cholangitis
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Donnelly 2006 (Continued)
Disease severity: not available.
Co-morbidity: not available.
Geographical location of the study: UK.
Inclusion criteria: people with chronic liver disease with suspected or previously documented
oesophageal varices
Exclusion criteria: not reported.
Index tests Index test: capsule endoscopy (PillCam ESO).
Criteria for oesophageal varices: other classification, adequately described and logically defined
Operator: 2 investigators without information about their expertise. Blinded from the reference
standard
Target condition and reference
standard(s)
Target condition: any oesophageal varices.
Reference standard: oesophago-gastro-duodenoscopy.
Criteria for oesophageal varices: not reported.
Prevalence of the target condition: 63% (5/8 participants).
Flow and timing
Comparative
Notes Observer variation: data on interobserver variation not reported.
Uninterpretable results: no data were reported.
Side effects or complications: no side effects or complications were described.
Type of publication: abstract.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Did the study enrol only
patients with suspected oe-




DOMAIN 2: Index Test All tests
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Were the index test results in-
terpreted without knowledge of




DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Patient sampling Cross-sectional cohort study design (screening cohort + surveillance cohort). Prospective, 3-centre
study
Patient characteristics and set-
ting
Participants:32participants (screening cohort: 10participants; surveillance cohort: 22participants)
mean age 57.2 ± 8 years. 20 men
Baseline diagnosis: not available.
Disease severity: not available.
Co-morbidity: not available.
Geographical location of the study: Italy, Israel, USA.
Inclusion criteria: aged ≥ 18 years with prior endoscopic confirmation of oesophageal varices or
clinically suspect portal hypertension
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Eisen 2006 (Continued)
Exclusion criteria: history of current or prior dysphagia; known Zenker’s diverticulum; known or
suspected intestinal obstruction; pregnancy; history of abdominal surgery of the gastrointestinal tract
(other than uncomplicated cholecystectomy or appendectomy); the presence of a cardiac pacemaker
or any other implanted electro-medical device; and any condition that precluded compliance with
the study or the PillCam ESO instructions (or both)
Index tests Index test: capsule endoscopy (PillCam ESO).
Criteria for oesophageal varices: the Japanese endoscopic classification (JSPH 1980).
Operator: no information of the operator expertise or number. Blinded from the reference standard
Target condition and reference
standard(s)
Target condition: any oesophageal varices.
Reference standard: oesophago-gastro-duodenoscopy.
Criteria for oesophageal varices: the Japanese endoscopic classification (JSPH 1980).
Operator: no information of the operator expertise or number. Blinded from the index test
Prevalence of the target condition: 72% (23/32 participants).
Flow and timing
Comparative
Notes Observer variation: no data on observer variation were reported.
Uninterpretable results: no data were reported.
Side effects or complications: no side effects or complications were described.
Type of publication: full text.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Did the study enrol only
patients with suspected oe-




DOMAIN 2: Index Test All tests
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Were the index test results in-
terpreted without knowledge of




DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Patient sampling Cross-sectional cohort (screening cohort + surveillance cohort) a single tertiary centre
Patient characteristics and set-
ting
Participants: 50 participants (34 men), mean age 58 years, range 25 to 74 years
Baseline diagnosis: aetiology: 24HCV, 7HCV+ alcohol, 6 alcohol, 6 non-alcoholic steatohepatitis,
27 other
Disease severity: mean MELD1 9.48, range 6 to 23; mean Child-Pugh score 6.8, range 5 to 13)
Co-morbidity: not available
Geographical location of the study: USA
Inclusion criteria: consecutive participants for oesophageal varice screening, i.e., peoplewith clinical
or histologically confirmed cirrhosis or for oesophageal varice surveillance, i.e., people who had
previously been diagnosed with oesophageal varices via oesophago-gastro-duodenoscopy and were
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repeating the test to assess for progression of varices. People who had previously undergone banding
of oesophageal varices were included in the study if they were stable and had not had a variceal
haemorrhage for ≥ 6 months
Exclusion criteria: dysphagia, known Zenker’s diverticulum, the presence of cardiac pacemaker or
other implantable electro-medical devices, pregnancy or a scheduled magnetic resonance imaging
within 7 days after capsule ingestion. People also were excluded if they had a history of or risk for
intestinal obstruction, including any prior abdominal surgery of the gastrointestinal tract other than
uncomplicated cholecystectomy or appendectomy
Index tests Index test: capsule endoscopy without further specification.
Criteria for oesophageal varices: high-risk varices according to the North Italian Endoscopic Club
(NIEC 1988).
Operator: capsule endoscopieswere read by 2 separate investigators, whowere blinded to oesophago-
gastro-duodenoscopy findings, patient medical history and reading of the other investigator. Both
capsule readers had prior experience in endoscopic evaluation and diagnosis of oesophageal varices.
Prior to the study, both readers underwent training as recommended by the capsule manufacturer,
consisting of review of a CD ROM and participation in an online course, which included review
of 10 cases of capsule endoscopy. Each capsule endoscopy was read twice by each investigator on 2
separate occasions at least 60 days apart. Capsule images were evaluated for the presence and grade
of oesophageal varices according to the same scale for oesophago-gastro-duodenoscopy. Intra- and
inter-rater were assessed
Target condition and reference
standard(s)
Target condition: presence of high-risk or oesophageal varices requiring treatment
Reference standard: oesophago-gastro-duodenoscopy on the same day or within 72 hours graded
by: F0, no varices; F1, small straight varices; F2, tortuous varices and < 50% of oesophageal radius;
F3, large and tortuous varices with or without red spots. Presence or absence of high-risk stigmata,
defined as neovascularisation or red or white spots was noted separately. Each observer decided
whether treatment was indicated based on presence of F2 or F3 varices or the presence of high-risk
stigmata on any size varix
The hepatologists were blinded to the results of the capsule endoscopy, but not to the participant’s
history or previous endoscopy findings
Prevalence of the target condition: high-risk varices 34% (17/50 participants); any varices 66%
(33/50 participants)
Flow and timing 55 participants were screened to participate in the study.
0 participants withdrawn from the study.
5 participants were not included: 2 participants refused, 1 participant had a history of an oesophageal
stricture, 2 participants had history of surgery on the gastrointestinal tract
Comparative
Notes Observer variation: data on observer variation were reported (inter-rater agreement kappa = 0.56;
intra-rater agreement: kappa = 0.61 for reader 1 and kappa = 0.41 for reader 2)
Uninterpretable results: data were reported
Side effects or complications: side effects or complications were described. 5 participants (10%)
had a mild amount of difficulty swallowing the capsule, and 4 participants (8%) had a moderate
amount of difficulty, 1 of whom had to swallow it in a sitting position
Type of publication: full text.
45Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Frenette 2008 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Did the study enrol only
patients with suspected oe-




DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of




DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
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Frenette 2008 (Continued)
Did all patients receive the same
reference standard?
Yes





Patient sampling Cross-sectional cohort (only screening cohort); prospective single-centre study
Patient characteristics and set-
ting
Participants: 24 participants. Mean age 52 ± 8.4 years, range 36 to 70 years. 14 (58%) were men
Baseline diagnosis: aetiology: 19 (79%) HCV. No other diagnostic information was provided
Disease severity: 17 (71%) Child-Pugh score B. No other information was provided
Co-morbidity: not available.
Geographical location of the study: not available.
Inclusion criteria: people awaiting liver transplantation scheduled for oesophago-gastro-duo-
denoscopy
Exclusion criteria: not available.
Index tests Index test: capsule endoscopy (PillCam ESO).
Criteria for oesophageal varices: other classification, adequately described and logically defined
Operator: 2 faculty experts, blinded from the reference standard.
Target condition and reference
standard(s)
Target condition: any oesophageal varices.
Reference standard: oesophago-gastro-duodenoscopy.
Criteria for oesophageal varices: other classification, adequately described and logically defined
Prevalence of the target condition: 50% (12/24 participants).
Flow and timing From 39 invited participants to participate, 24 were enrolled. No information about the reasons for
the declinations
Comparative
Notes Observer variation: data on observer variation were reported (kappa = 0.55).
Uninterpretable results: data were not reported.
Side effects or complications: no side effects or complications were described.
Type of publication: abstract.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Did the study enrol only
patients with suspected oe-




DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of




DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
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Patient sampling Cross-sectional cohort (only screening cohort); prospective single-centre study
Patient characteristics and set-
ting
Participants: 21 participants. No age or sex were provided.
Baseline diagnosis: cirrhosis.
Disease severity: not available.
Co-morbidity: not available.
Geographical location of the study: not available.
Inclusion criteria: people with cirrhosis without previous oesophageal varices screening or history
of previous gastrointestinal bleeding
Exclusion criteria: not available.
Index tests Index test: capsule endoscopies without further specification.
Criteria for oesophageal varices: not available.
Operator: no information of the operator expertise or number. Blinded from the reference standard
Target condition and reference
standard(s)
Target condition: any oesophageal varices.
Reference standard: oesophago-gastro-duodenoscopy.
Criteria for oesophageal varices: not available.
Prevalence of the target condition: 43% (9/21 participants)
Flow and timing 1 participant was unable to swallow the capsule and was not included.
1 uninterpretable result was reported and classified as false negative
Comparative
Notes Observer variation: no data on observer variation were reported.
Uninterpretable results: data were reported (1 participant with uninterpretable result was included
in the analysis)
Side effects or complications: data on side effects were reported. 13% of participants experienced
moderate or severe difficulty swallowing capsule endoscopy and 10% experienced moderate-severe
discomfort with the capsule endoscopy
Type of publication: abstract.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
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Groce 2007 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Did the study enrol only
patients with suspected oe-




DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of




DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Ishiguro 2012
Study characteristics
Patient sampling Cross-sectional cohort (screening cohort + surveillance cohort); prospective single-centre study
Patient characteristics and set-
ting
Participants: 29 participants (19 screening, 10 surveillance). 1 person excluded because the capsule
did not reach the oesophago-gastric junction. 9 men, mean age 66 ± 6.6 years
Baseline diagnosis: aetiology: 5 HCV, 4 alcohol, 1 primary biliary cirrhosis, 17 hepatocellular
carcinoma, 2 other
Disease severity: 14 Child-Pugh score A, 14 Child-Pugh score B, 1 Child-Pugh score C
Inclusion criteria: aged ≥ 18 years, prior endoscopic confirmation of oesophageal varice and
currently under clinical surveillance, or suspected portal hypertension with current endoscopic
screening for oesophageal varice
Exclusion criteria: history of (or current) dysphagia; known oesophageal diverticulum; known or
suspected intestinal obstruction; pregnancy; history of gastrointestinal surgery other than uncom-
plicated cholecystectomy or appendectomy; having an implanted cardiac pacemaker or any other
electro-medical device and any condition that might preclude compliance with the study or the
PillCam ESO instructions, or both
Index tests Index test: endoscopic capsule. PillCam ESO; Given Imaging, Yokneam, Israel
Criteria for oesophageal varices: Japanese endoscopic classification system.
Operator: 3 experienced endoscopists who were blinded to each participant’s history, with the
exception of liver cirrhosis
Target condition and reference
standard(s)
Target condition: presence of any and large oesophageal varices. Presence of red marks
Reference standard: oesophago-gastroduo-denoscopy.
Criteria for oesophageal varices: oesophageal varices were recorded according to the general rules
of the Japanese Society for Portal Hypertension. Endoscopic signs predictive of oesophageal varice
bleeding comprised moderate or large (F2 or F3) blue varices with marked red signs (RC2 or RC3)
on their surface
Prevalence of the target condition: 79% (22/28 participants).
Flow and timing 1 participant was not included in the analysis due to uninterpretable result (the capsule did not
reach oesophago-gastric junction)
Comparative
Notes Observer variation: no data on observer variation were reported.
Uninterpretable results: data were reported.
Side effects or complications: no side effects or complications were described.
Type of publication: full text.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
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Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Did the study enrol only
patients with suspected oe-




DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of




DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
52Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Lapalus 2006
Study characteristics
Patient sampling Cross-sectional (only screening cohort); prospective cohort single-centre study. Included both in-
patients and outpatients
Patient characteristics and set-
ting
Participants: 21 participants. Mean age 62 years, range 49 to 79 years. Sex: not available
Baseline diagnosis: cirrhosis. Aetiology: 5 HCV infection, 15 alcohol, 2 autoimmune hepatitis, 1
non-alcoholic steatohepatitis, 1 haemochromatosis
Disease severity: Mean MELD score 10.5 and mean Child-Pugh score 7.3. Child-Pugh score A
62%; Child-Pugh score B 28%; Child-Pugh score C 10%
Co-morbidity: not available.
Geographical location of the study: France
Inclusion criteria: people with recently diagnosed cirrhosis.
Exclusion criteria: people aged < 18 years, pregnant, people with known or suspected gastrointesti-
nal obstruction or strictures, people with a cardiac pacemaker or other implanted electro-medical
devices, people with swallowing disorders or dysphagia, people who had previously received endo-
scopic or surgical oesophageal treatment
Index tests Index test: capsule endoscopy (PillCam ESO).
Criteria for oesophageal varices: conventional oesophago-gastro-duodenoscopy grading system.
Operator: 1 experienced capsule endoscopist, blinded from the reference standard
Target condition and reference
standard(s)
Target condition: any oesophageal varices.
Reference standard: oesophago-gastro-duodenoscopy.
Criteria for oesophageal varices: not available.
Prevalence of the target condition: 80% (16/20 participants).
Flow and timing 1 participant was unable to swallow the capsule and was not included in the analysis
Comparative
Notes Observer variation: no data on observer variation were reported.
Uninterpretable results: data were reported.
Side effects or complications: data on side effects were reported. 10% of participants experienced
difficulties in swallowing capsule endoscopy
Type of publication: full text.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
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Lapalus 2006 (Continued)
Did the study avoid inappropri-
ate exclusions?
Yes
Did the study enrol only
patients with suspected oe-




DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of




DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
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Lapalus 2009
Study characteristics
Patient sampling Cross-sectional cohort (only screening cohort); prospective 9-centre study. Included inpatients and
outpatients
Patient characteristics and set-
ting
Participants: 120 participants. Mean age 58 years, range 23 to 84 years. 72 (60%) men. However,
only 113 participants were analysed (participants who had PillCam ESO)
Baseline diagnosis: cirrhosis. Aetiology: 17 HCV, 78 alcohol, 14 non-alcoholic steatohepatitis, 9
other causes
Disease severity: Child-Pugh score A 48%, Child-Pugh score B 30%, Child-Pugh score C 22%.
Mean Child-Pugh score 7.4. Mean MELD score 11.5. Portal hypertension was related to cirrhosis
in 113 participants
Co-morbidity: not available.
Geographical location of the study: France.
Inclusion criteria: people with recently diagnosed cirrhosis.
Exclusion criteria: aged < 18 years, pregnant, people with known or suspected gastrointestinal
obstruction or strictures, people with cardiac pacemaker or other implanted electro-medical de-
vices, people with swallowing disorders or dysphagia, people with previous endoscopic or surgical
oesophageal treatment
Representative spectrum? Yes. “Recently diagnosed cirrhosis” and aetiology of liver diseases were
described. “All the patients had their procedure performed for screening purpose.”
Index tests Index test: capsule endoscopy (PillCam ESO).
Criteria for oesophageal varices: other classification, adequately described and logically defined
Operator: 2 independent experienced endoscopists. Blinded from the reference standard
Target condition and reference
standard(s)
Target condition: any and large oesophageal varices.
Reference standard: oesophago-gastro-duodenoscopy.
Criteria for oesophageal varices: other classification, adequately described and logically defined
Prevalence of the target condition: 63% (71/113 participants).
Flow and timing Capsule endoscopy procedure was feasible in 113/120 (94%) participants. 7 people were not in-
cluded in the analysis due to uninterpretable results
Comparative
Notes Observer variation: data on observer variation were reported. Kappa for detection of varices = 0.
582 in only 107 participants (lost for 6 participants)
Uninterpretable results: data were reported.
Side effects or complications: no severe side effects or complications were observed.
Type of publication: full text.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Lapalus 2009 (Continued)
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Did the study enrol only
patients with suspected oe-




DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of




DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
No
Were all patients included in the
analysis?
Yes
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Patient sampling Cross-sectional cohort (screening cohort + surveillance cohort); prospective single-centre study
Patient characteristics and set-
ting
Participants: 20 participants (8 for screening; 12 for surveillance, of which 9 previous banding)
Mean age 50.7 years, range 34 to 61 years. 14 (70%) men.
Baseline diagnosis: cirrhosis. Aetiology: 25% HCV; 30% non-alcoholic steatohepatitis; 10% al-
coholic; 35% combination
Disease severity: mean Child-Pugh score 7.9, range 5 to 12. Mean MELD score 12.9, range 7 to
25
Co-morbidity: not available.
Geographical location of the study: USA.
Inclusion criteria: aged > 18 years with cirrhosis.
Exclusion criteria: unable to give informed consent; evidence of active gastrointestinal bleeding, or
known or suspected obstruction, stricture or fistula of the gastrointestinal tract; implanted electro-
medical devices; difficulty swallowing
Index tests Index test: capsule endoscopy without any further specification.
Criteria for oesophageal varices: based on estimation of size: small, medium, large, very large
Operator: no previous experience with capsule endoscopy. Blinded from the reference standard
Target condition and reference
standard(s)
Target condition: oesophageal varices.
Reference standard: oesophago-gastro-duodenoscopy.
Criteria for oesophageal varices: other classification, adequately described and logically defined
Prevalence of the target condition: 95% (19/20 participants).
Flow and timing 13 people declined to participate and 3 were excluded due to inability to obtain consent
Unreliable results: 2 participants who were included in the analysis
Comparative
Notes Observer variation: no data on observer variation were reported.
Uninterpretable results: data were reported.
Side effects or complications: data on side effects were described. The post-study analogue scale
showed a greater level of anxiety before oesophago-gastro-duodenoscopy (mean 2.75/10) versus
capsule endoscopy (mean 1.5/10)
Type of publication: full text.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Pena 2008 (Continued)
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Did the study enrol only
patients with suspected oe-




DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of




DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Patient sampling Cross-sectional cohort (screening cohort + surveillance cohort); prospective single-centre study
Patient characteristics and set-
ting
Participants: 30 participants (11 for screening, 19 for surveillance). Mean age 54.4 years, range 43
to 69 years. 30 (100%) men. Outpatients only
Baseline diagnosis: cirrhosis. Aetiology: 14 HCV, 8 alcohol, 7 alcohol + HCV; 1 cryptogenic
Disease severity: mean MELD score 12.5; mean Child-Pugh score 6.3.
Co-morbidity: not available.
Geographical location of the study: USA.
Inclusion criteria: cirrhosis. People scheduled for oesophago-gastro-duodenoscopy for screening
or surveillance of oesophageal varice
Exclusion criteria: not available.
Index tests Index test: string wireless capsule endoscopy (device was modified attaching a string to control
movement up and down the oesophagus)
Criteria for oesophageal varices: other classification, adequately described and logically defined
Operator: 1 experienced endoscopist, but no information about experience with index test. Blinded
from the reference standard
Target condition and reference
standard(s)
Target condition: oesophageal varices.
Reference standard: oesophago-gastro-duodenoscopy.
Criteria for oesophageal varices: other classification, adequately described and logically defined
Prevalence of the target condition: 83% (25/30 participants).
Flow and timing Reference standard and index test timing: variable. 20 participants were at the same day, 3 within
24 hours, 2 within 14 days, 1 within 1 month, 4 after 1 month
Comparative
Notes Observer variation: no data on observer variation were reported.
Uninterpretable results: uninterpretable results were not reported.
Side effects or complications: data on side effects or complications were reported. The string wire-
less capsule was deemed to be easy or mildly difficult to swallow by 79.3% (23/29) of participants,
moderately difficult by 17.2% (5/29), very difficult by 3.5% (1/29). Pulling the string capsule out
of the oesophagus caused no or minimal discomfort in 82.8% (24/29) and moderate discomfort in
17.2% (5/29)
Type of publication: full text.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Ramirez 2005 (Continued)
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Did the study enrol only
patients with suspected oe-




DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of




DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Patient sampling Cross-sectional cohort (screening cohort + surveillance cohort); prospective single-centre study
Patient characteristics and set-
ting
Participants: 37 participants (18 screening, 19 surveillance); 28 male, mean age 56 years (range 21
to 78 years)
Baseline diagnosis: aetiology: 11 alcohol; 8 non-alcoholic steatohepatitis; 7 HCV; 5 alcohol +
HCV; 6 other
Disease severity: Child-Pugh score A 23; Child-Pugh score B 9; Child-Pugh score C 5
Co-morbidity: not available.
Geographical location of the study: USA.
Inclusion criteria: men aged > 18 years, or women aged > 18 years with a negative pre-procedure
pregnancy test or of non-reproductive potential; inpatient or outpatient; able to provide informed
consent
Exclusion criteria: pregnancy; presence of a known Zenker’s diverticulum; swallowing disorder;
known intestinal diverticulum; suspected intestinal obstruction or stricture; pseudo-obstruction;
active variceal bleeding; presence of a cardiac pacemaker or implanted electro-medical device; sus-
pected or known Crohn’s disease, presence of ileostomy
Index tests Index test: capsule endoscopy (PillCam ESO)
Criteria for oesophageal varices: according to the North Italian Endoscopic Club (NIEC 1988).
Operator: blinded investigator and assessed using the same criteria.
Target condition and reference
standard(s)
Target condition: any and large oesophageal varices.
Reference standard: oesophago-gastro-duodenoscopy.
Criteria for oesophageal varices: as defined by the New Italian Endoscopic Club (NIEC 1988).
Prevalence of the target condition: 91% (31/34 participants).
Flow and timing Uninterpretable results: 3 cases not included in the analysis (in 2 participants, no capsule results
were obtained due to capsule malfunction and inappropriate connection of the transmitter. In 1
participant, the capsule did not remain in the oesophagus long enough to provide adequate images)
Comparative
Notes Observer variation: no data on observer variation were reported.
Uninterpretable results: 3 cases not included in the analysis.
Side effects or complications: no side effects or complications were described.
Type of publication: full text.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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Schreibman 2011 (Continued)
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Did the study enrol only
patients with suspected oe-




DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of




DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
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Schreibman 2011 (Continued)





Patient sampling Cross-sectional cohort (only screening cohort); prospective single-centre study
Patient characteristics and set-
ting
Participants: 34 participants with end-stage liver disease.
Baseline diagnosis: not reported.
Disease severity: not reported.
Co-morbidity: not reported.
Geographical location of the study: not reported.
Inclusion criteria: not reported.
Exclusion criteria: not reported.
Index tests Index test: oesophageal capsule endoscopy without any further specification
Criteria for oesophageal varices: not reported.
Operator: performed by ESO-trained gastroenterologists.
Target condition and reference
standard(s)
Target condition: presence of any and large oesophageal varices.
Reference standard: oesophago-gastro-duodenoscopy.
Criteria for oesophageal varices: not reported.
Prevalence of the target condition: 82% (28/34 participants).
Flow and timing
Comparative
Notes Observer variation: no data on observer variation were reported.
Uninterpretable results: data on uninterpretable results were not reported.
Side effects or complications: no side effects or complications with ESO were described. 4 minor
events with oesophago-gastro-duodenoscopy (hypotension, hypoxia, and possible aspiration)
Type of publication: abstract.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
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Sharma 2009 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Did the study enrol only
patients with suspected oe-




DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of




DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Stipho 2012
Study characteristics
Patient sampling Cross-sectional cohort (screening cohort + surveillance cohort); perspective single-centre study
Patient characteristics and set-
ting
Participants: 100 participants with cirrhosis (33 screening; 67 surveillance), 99 male; mean age 55.
9 years
Baseline diagnosis: aetiology HCV alcohol alone or in combination in 91 participants
Disease severity: mean Child-Pugh score 5.9; mean MELD 10.8.
Co-morbidity: not reported.
Geographical location of the study: USA.
Inclusion criteria: people with clinically or biopsy-confirmed cirrhosis (or both) scheduled to
undergo oesophago-gastro-duodenoscopy for screening or surveillance purposes
Exclusion criteria: not reported.
Index tests Index test: capsule endoscopy. String capsule endoscopy was carried out by using the small bowel
capsule endoscopy device (PillCam SB; Given Imaging Ltd, Yoqneam, Israel) to which a tethering
device consisting of a sleeve and strings was attached
Criteria for oesophageal varices: according to the North Italian Endoscopic Club (NIEC 1988).
Operator: an endoscopist blinded to the oesophago-gastro-duodenoscopy results
Target condition and reference
standard(s)
Target condition: presence of any oesophageal varices and red marks.
Reference standard: oesophago-gastro-duodenoscopy.
Criteria for oesophageal varices: according to the North Italian Endoscopic Club (NIEC 1988).
Prevalence of the target condition: 82% (82/100 participants).
Flow and timing
Comparative
Notes Observer variation: no data on observer variation were reported.
Uninterpretable results: data on uninterpretable were not reported.
Side effects or complications: no side effects or complications were described.
Type of publication: full text.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
65Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Stipho 2012 (Continued)
Did the study enrol only
patients with suspected oe-




DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of




DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
HBV: hepatitis B virus; HCV: hepatitis C virus; MELD: model for end-stage liver disease.
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
de Franchis 2005 Full manuscript was added; therefore, we excluded the abstract study
Delvaux 2008 Aim was not for diagnostic test for oesophageal varices, it was for any oesophageal disease. No 2 x 2 table
Ganc 2010 Different aim of the study: to detect with endocapsule small bowel lesions in people with portal hypertension
due to schistosomiasis
Ishiguro 2008 Full manuscript was added; therefore, we excluded the abstract study
Matheus 2006 Only half of the participants have the reference standard test available for comparison of the index test within
1 year. No 2 x 2 table
Muhammad 2006 Lack of information of the results, including 2 x 2 table, participants characteristics, reference standard, index
test, etc
Wigg 2011 Not possible to extract data for 2 x 2 table.
67Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D A T A
Presented below are all the data for all of the tests entered into the review.






1 Any varices - All the studies 15 936
2 Any varices - only string capsule 2 130
3 Any varices - studies at low risk
of bias for QUADAS-2 ’patient
selection’ domain
7 396
4 Any varices - studies at low risk
of bias for QUADAS-2 ’flow
and timing’ domain
9 687
5 Any varices - only full-text
studies
11 849
6 Large varices - all the studies 6 537
7 Red marks - all the studies 3 150
Test 1. Any varices - All the studies.
Review: Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
Test: 1 Any varices - All the studies
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Aoyama 2014 51 0 20 48 0.72 [ 0.60, 0.82 ] 1.00 [ 0.93, 1.00 ]
Chavalitdhamrong 2012 36 10 10 9 0.78 [ 0.64, 0.89 ] 0.47 [ 0.24, 0.71 ]
de Franchis 2008 152 13 28 95 0.84 [ 0.78, 0.89 ] 0.88 [ 0.80, 0.93 ]
Donnelly 2006 5 2 0 1 1.00 [ 0.48, 1.00 ] 0.33 [ 0.01, 0.91 ]
Eisen 2006 23 1 0 8 1.00 [ 0.85, 1.00 ] 0.89 [ 0.52, 1.00 ]
Gerson 2008 9 2 3 10 0.75 [ 0.43, 0.95 ] 0.83 [ 0.52, 0.98 ]
Groce 2007 7 2 2 10 0.78 [ 0.40, 0.97 ] 0.83 [ 0.52, 0.98 ]
Ishiguro 2012 21 1 1 5 0.95 [ 0.77, 1.00 ] 0.83 [ 0.36, 1.00 ]
Lapalus 2006 13 0 3 4 0.81 [ 0.54, 0.96 ] 1.00 [ 0.40, 1.00 ]
Lapalus 2009 55 6 16 36 0.77 [ 0.66, 0.87 ] 0.86 [ 0.71, 0.95 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
(Continued . . . )
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Pena 2008 13 0 6 1 0.68 [ 0.43, 0.87 ] 1.00 [ 0.03, 1.00 ]
Ramirez 2005 24 0 1 5 0.96 [ 0.80, 1.00 ] 1.00 [ 0.48, 1.00 ]
Schreibman 2011 20 1 11 2 0.65 [ 0.45, 0.81 ] 0.67 [ 0.09, 0.99 ]
Sharma 2009 28 2 0 4 1.00 [ 0.88, 1.00 ] 0.67 [ 0.22, 0.96 ]
Stipho 2012 69 5 13 13 0.84 [ 0.74, 0.91 ] 0.72 [ 0.47, 0.90 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 2. Any varices - only string capsule.
Review: Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
Test: 2 Any varices - only string capsule
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Ramirez 2005 24 0 1 5 0.96 [ 0.80, 1.00 ] 1.00 [ 0.48, 1.00 ]
Stipho 2012 69 5 13 13 0.84 [ 0.74, 0.91 ] 0.72 [ 0.47, 0.90 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 3. Any varices - studies at low risk of bias for QUADAS-2 ’patient selection’ domain.
Review: Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
Test: 3 Any varices - studies at low risk of bias for QUADAS-2 ’patient selection’ domain
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Aoyama 2014 51 0 20 48 0.72 [ 0.60, 0.82 ] 1.00 [ 0.93, 1.00 ]
Chavalitdhamrong 2012 36 10 10 9 0.78 [ 0.64, 0.89 ] 0.47 [ 0.24, 0.71 ]
Gerson 2008 9 2 3 10 0.75 [ 0.43, 0.95 ] 0.83 [ 0.52, 0.98 ]
Groce 2007 7 2 2 10 0.78 [ 0.40, 0.97 ] 0.83 [ 0.52, 0.98 ]
Lapalus 2006 13 0 3 4 0.81 [ 0.54, 0.96 ] 1.00 [ 0.40, 1.00 ]
Lapalus 2009 55 6 16 36 0.77 [ 0.66, 0.87 ] 0.86 [ 0.71, 0.95 ]
Sharma 2009 28 2 0 4 1.00 [ 0.88, 1.00 ] 0.67 [ 0.22, 0.96 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 4. Any varices - studies at low risk of bias for QUADAS-2 ’flow and timing’ domain.
Review: Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
Test: 4 Any varices - studies at low risk of bias for QUADAS-2 ’flow and timing’ domain
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Aoyama 2014 51 0 20 48 0.72 [ 0.60, 0.82 ] 1.00 [ 0.93, 1.00 ]
Chavalitdhamrong 2012 36 10 10 9 0.78 [ 0.64, 0.89 ] 0.47 [ 0.24, 0.71 ]
de Franchis 2008 152 13 28 95 0.84 [ 0.78, 0.89 ] 0.88 [ 0.80, 0.93 ]
Donnelly 2006 5 2 0 1 1.00 [ 0.48, 1.00 ] 0.33 [ 0.01, 0.91 ]
Eisen 2006 23 1 0 8 1.00 [ 0.85, 1.00 ] 0.89 [ 0.52, 1.00 ]
Groce 2007 7 2 2 10 0.78 [ 0.40, 0.97 ] 0.83 [ 0.52, 0.98 ]
Pena 2008 13 0 6 1 0.68 [ 0.43, 0.87 ] 1.00 [ 0.03, 1.00 ]
Sharma 2009 28 2 0 4 1.00 [ 0.88, 1.00 ] 0.67 [ 0.22, 0.96 ]
Stipho 2012 69 5 13 13 0.84 [ 0.74, 0.91 ] 0.72 [ 0.47, 0.90 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 5. Any varices - only full-text studies.
Review: Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
Test: 5 Any varices - only full-text studies
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Aoyama 2014 51 0 20 48 0.72 [ 0.60, 0.82 ] 1.00 [ 0.93, 1.00 ]
Chavalitdhamrong 2012 36 10 10 9 0.78 [ 0.64, 0.89 ] 0.47 [ 0.24, 0.71 ]
de Franchis 2008 152 13 28 95 0.84 [ 0.78, 0.89 ] 0.88 [ 0.80, 0.93 ]
Eisen 2006 23 1 0 8 1.00 [ 0.85, 1.00 ] 0.89 [ 0.52, 1.00 ]
Ishiguro 2012 21 1 1 5 0.95 [ 0.77, 1.00 ] 0.83 [ 0.36, 1.00 ]
Lapalus 2006 13 0 3 4 0.81 [ 0.54, 0.96 ] 1.00 [ 0.40, 1.00 ]
Lapalus 2009 55 6 16 36 0.77 [ 0.66, 0.87 ] 0.86 [ 0.71, 0.95 ]
Pena 2008 13 0 6 1 0.68 [ 0.43, 0.87 ] 1.00 [ 0.03, 1.00 ]
Ramirez 2005 24 0 1 5 0.96 [ 0.80, 1.00 ] 1.00 [ 0.48, 1.00 ]
Schreibman 2011 20 1 11 2 0.65 [ 0.45, 0.81 ] 0.67 [ 0.09, 0.99 ]
Stipho 2012 69 5 13 13 0.84 [ 0.74, 0.91 ] 0.72 [ 0.47, 0.90 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
71Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Test 6. Large varices - all the studies.
Review: Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
Test: 6 Large varices - all the studies
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
de Franchis 2008 62 9 17 200 0.78 [ 0.68, 0.87 ] 0.96 [ 0.92, 0.98 ]
Frenette 2008 11 4 6 19 0.65 [ 0.38, 0.86 ] 0.83 [ 0.61, 0.95 ]
Ishiguro 2012 12 3 1 12 0.92 [ 0.64, 1.00 ] 0.80 [ 0.52, 0.96 ]
Lapalus 2009 27 9 8 69 0.77 [ 0.60, 0.90 ] 0.88 [ 0.79, 0.95 ]
Schreibman 2011 4 2 13 15 0.24 [ 0.07, 0.50 ] 0.88 [ 0.64, 0.99 ]
Sharma 2009 10 2 1 21 0.91 [ 0.59, 1.00 ] 0.91 [ 0.72, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 7. Red marks - all the studies.
Review: Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
Test: 7 Red marks - all the studies
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Chavalitdhamrong 2012 9 3 10 24 0.47 [ 0.24, 0.71 ] 0.89 [ 0.71, 0.98 ]
Ishiguro 2012 16 2 1 3 0.94 [ 0.71, 1.00 ] 0.60 [ 0.15, 0.95 ]
Stipho 2012 32 6 7 37 0.82 [ 0.66, 0.92 ] 0.86 [ 0.72, 0.95 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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A P P E N D I C E S
Appendix 1. Search strategies
Appendix A
Capsule Endoscopy
Database Time span Search strategy
The Cochrane Hepato-Biliary Group Di-
agnostic Test Accuracy Studies Register
October 2013 (*esophag* ANDvari* AND (capsule* AND (enteroscop*OR
endoscop* OR *esophagoscop* or pillcam or endocapsule or
microcam or ’video capsule*’ or videocapsule*)
MEDLINE (Ovid SP) 1950 to
October 2013
#1 (esophag* varic* or esophag* varix or esophago gastric
varic* or esophago gastric varix or gastro esophag* varic* or
gastro esophag* varix or gastro oesophag* varic* or gastro
oesophag* varix or gastroesophag* varic* or gastroesophag*
varix or gastrooesophag* varic* or gastrooesophag* varix or oe-
sophag* varic* or oesophag* varix or oesophago gastric varic*
or oesophago gastric varix or paraesophag* varic* or parae-
sophag* varix or paraoesophag* varic* or paraoesophag* varix
or periesophag* varic* or periesophag* varix or perioesophag*
varic* or perioesophag* varix).mp.
#2 “Esophageal and Gastric Varices”/
#3 2 or 1
#4 (capsule enteroscop* or enteroscop* capsule* or capsule
endoscop* or endoscop* capsule* or capsule esophagoscop*
or capsule oesophagoscop* or esophag* capsule* or oesophag*
capsule* or pillcam or endocapsule or microcam or video cap-
sule* or videocapsule*).mp.
#5 4 and 3
EMBASE (Ovid SP) 1980 to October 2013 #1 (esophag* varic* or esophag* varix or esophago gastric
varic* or esophago gastric varix or gastro esophag* varic* or
gastro esophag* varix or gastro oesophag* varic* or gastro
oesophag* varix or gastroesophag* varic* or gastroesophag*
varix or gastrooesophag* varic* or gastrooesophag* varix or oe-
sophag* varic* or oesophag* varix or oesophago gastric varic*
or oesophago gastric varix or paraesophag* varic* or parae-
sophag* varix or paraoesophag* varic* or paraoesophag* varix
or periesophag* varic* or periesophag* varix or perioesophag*
varic* or perioesophag* varix).mp.
#2 “Esophageal and Gastric Varices”/
#3 2 or 1
#4 (capsule enteroscop* or enteroscop* capsule* or capsule
endoscop* or endoscop* capsule* or capsule esophagoscop*
or capsule oesophagoscop* or esophag* capsule* or oesophag*
capsule* or pillcam or endocapsule or microcam or video cap-
sule* or videocapsule*).mp.
#5 4 and 3
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(Continued)
ACP Journal Club (Ovid SP) 1991 to October 2013 #1 (esophag* varic* or esophag* varix or esophago gastric
varic* or esophago gastric varix or gastro esophag* varic* or
gastro esophag* varix or gastro oesophag* varic* or gastro
oesophag* varix or gastroesophag* varic* or gastroesophag*
varix or gastrooesophag* varic* or gastrooesophag* varix or oe-
sophag* varic* or oesophag* varix or oesophago gastric varic*
or oesophago gastric varix or paraesophag* varic* or parae-
sophag* varix or paraoesophag* varic* or paraoesophag* varix
or periesophag* varic* or periesophag* varix or perioesophag*
varic* or perioesophag* varix).mp.
#2 “Esophageal and Gastric Varices”/
#3 2 or 1
#4 (capsule enteroscop* or enteroscop* capsule* or capsule
endoscop* or endoscop* capsule* or capsule esophagoscop*
or capsule oesophagoscop* or esophag* capsule* or oesophag*
capsule* or pillcam or endocapsule or microcam or video cap-
sule* or videocapsule*).mp.
#5 4 and 3
Database of Abstracts of Reviews of Effects
(DARE) (Ovid SP)
Third quarter 2013 #1 (esophag* varic* or esophag* varix or esophago gastric
varic* or esophago gastric varix or gastro esophag* varic* or
gastro esophag* varix or gastro oesophag* varic* or gastro
oesophag* varix or gastroesophag* varic* or gastroesophag*
varix or gastrooesophag* varic* or gastrooesophag* varix or oe-
sophag* varic* or oesophag* varix or oesophago gastric varic*
or oesophago gastric varix or paraesophag* varic* or parae-
sophag* varix or paraoesophag* varic* or paraoesophag* varix
or periesophag* varic* or periesophag* varix or perioesophag*
varic* or perioesophag* varix).mp.
#2 “Esophageal and Gastric Varices”/
#3 2 or 1
#4 (capsule enteroscop* or enteroscop* capsule* or capsule
endoscop* or endoscop* capsule* or capsule esophagoscop*
or capsule oesophagoscop* or esophag* capsule* or oesophag*
capsule* or pillcam or endocapsule or microcam or video cap-
sule* or videocapsule*).mp.
#5 4 and 3




#1 (esophag* varic* or esophag* varix or esophago gastric
varic* or esophago gastric varix or gastro esophag* varic* or
gastro esophag* varix or gastro oesophag* varic* or gastro
oesophag* varix or gastroesophag* varic* or gastroesophag*
varix or gastrooesophag* varic* or gastrooesophag* varix or oe-
sophag* varic* or oesophag* varix or oesophago gastric varic*
or oesophago gastric varix or paraesophag* varic* or parae-
sophag* varix or paraoesophag* varic* or paraoesophag* varix
or periesophag* varic* or periesophag* varix or perioesophag*
varic* or perioesophag* varix).mp.
#2 “Esophageal and Gastric Varices”/
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(Continued)
#3 2 or 1
#4 (capsule enteroscop* or enteroscop* capsule* or capsule
endoscop* or endoscop* capsule* or capsule esophagoscop*
or capsule oesophagoscop* or esophag* capsule* or oesophag*
capsule* or pillcam or endocapsule or microcam or video cap-
sule* or videocapsule*).mp.
#5 4 and 3
NHS Economic Evaluation Database
(NHSEED)
Third quarter 2013 #1 (esophag* varic* or esophag* varix or esophago gastric
varic* or esophago gastric varix or gastro esophag* varic* or
gastro esophag* varix or gastro oesophag* varic* or gastro
oesophag* varix or gastroesophag* varic* or gastroesophag*
varix or gastrooesophag* varic* or gastrooesophag* varix or oe-
sophag* varic* or oesophag* varix or oesophago gastric varic*
or oesophago gastric varix or paraesophag* varic* or parae-
sophag* varix or paraoesophag* varic* or paraoesophag* varix
or periesophag* varic* or periesophag* varix or perioesophag*
varic* or perioesophag* varix).mp.
#2 “Esophageal and Gastric Varices”/
#3 2 or 1
#4 (capsule enteroscop* or enteroscop* capsule* or capsule
endoscop* or endoscop* capsule* or capsule esophagoscop*
or capsule oesophagoscop* or esophag* capsule* or oesophag*
capsule* or pillcam or endocapsule or microcam or video cap-
sule* or videocapsule*).mp.
#5 4 and 3
Science Citation Index Expanded 1955 to October 2013 #1 TS=(esophag* varic* OR esophag* varix OR esophago gas-
tric varic*OResophago gastric varixORgastro esophag* varic*
OR gastro esophag* varix OR gastro oesophag* varic* OR
gastro oesophag* varix OR gastroesophag* varic* OR gastroe-
sophag* varix OR gastrooesophag* varic* OR gastrooesophag*
varix OR oesophag* varic* OR oesophag* varixOR oesophago
gastric varic* OR oesophago gastric varix OR paraesophag*
varic* OR paraesophag* varix OR paraoesophag* varic* OR
paraoesophag* varix OR periesophag* varic* OR periesophag*
varix OR perioesophag* varic* OR perioesophag* varix)
#2TS=(capsule enteroscop*ORenteroscop* capsule*ORcap-
sule endoscop* OR endoscop* capsule* OR capsule esophago-
scop* OR capsule oesophagoscop* OR esophag* capsule* OR
oesophag* capsule* OR pillcam OR endocapsule OR micro-
cam OR video capsule* OR videocapsule*)
#3 #2 AND #1
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Appendix 2. QUADAS-2
Domain 1. Participant selection 2. Index test 3. Reference standard 4. Flow and timing
Signalling questions
and criteria
Q.1: “Was a consecutive
or random sample of par-
ticipants enrolled?”
Yes - If the study reports
on a consecutive or a ran-
dom selection of partici-
pants
No - if the study reports
on another form of selec-
tion of participants
Unclear - if the study
does not report on how
the participants were en-
rolled
Q.2: “Was a case-control
design avoided?”
Yes - if the case-control
design was avoided.
No - if the study was a
case-control.
Unclear - if the study de-
sign was not clear.
Q.3: “Did the study avoid
inappropriate exclusions?”
Yes - if the study defi-
nition of exclusion crite-
ria are appropriate (i.e.
, concerning the risk of
capsule impact) and all
exclusions are reported
No - if exclusion criteria
are inappropriate and ex-
clusions are not reported
Unclear - if the study
does not report causes of
exclusions.
Q.4: “Did the study enrol
only participants with sus-
pected oesophageal varices
not until diagnosed?”
Yes - if the study enrolled
only partici-
pants with suspected oe-
sophageal varices not un-
til diagnosed
Q.1: “Were the index test
results interpreted without
knowledge of the results of
the reference standard?”
Yes - if the study reports
that the results of the in-
dex test were interpreted
without the knowledge
of the results of the ref-
erence standard
No - if the study reports
that results of the in-
dex test were interpreted
with the results of the ref-
erence standard
Unclear - if the study
does not report informa-
tion about blinding of
the results of the index
test and reference stan-
dard
Q.1: “Is the reference stan-
dard likely to correctly
classify the target condi-
tion?”
Yes - if the reference stan-
dard correctly classifies
oesophageal varices
No - if there is some
doubt if the reference
standard classifies oe-
sophageal varices
Unclear - if the study
does not report on the
reference standard used
Q.2: “Were the reference
standard results inter-
preted without the knowl-
edge of the results of the in-
dex test?”
Yes - if the study reports
that the results of the
reference standard were
interpreted without the
knowledge of the results
of the index test
No - if the study reports
that the results of the ref-
erence standard were in-
terpreted with the results
of the test index
Unclear - if the study
does not report informa-
tion about blinding of
the results of the refer-
ence standard and the in-
dex test
Q.1: “Was there an ap-
propriate interval between
the index test and the ref-
erence standard?”
Yes - if the interval be-
tween the index test and
the reference standard
was less than 14 days;
No - if the interval was
longer than 14 days;
Unclear - if the study
does not report the in-
terval between the in-
dex test and the reference
standard
Q.2: “Did all participants
receive the same reference
standard?”
Yes - if the study has only
one reference standard
for all the participants
(OGD with appropri-
ate classification of oe-
sophageal varices)
No - if the study has
more than one reference
standards.
Unclear- if the study is
not clear about the refer-
ence standard used
Q.3 “Were all partic-
ipants included in the
analysis?”
Answer:
Yes - if all enrolled partic-
ipants were included in
the analysis (even in the
case of uninterpretable
index test result)
No - if any participant
was excluded from the
analysis for any reason
Unclear - if it is not clear
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(Continued)
No - if the study en-
rolled any participants
with already known oe-
sophageal varices
Unclear - if the charac-
teristics of enrolled par-
ticipants are not ade-
quately defined
about the exclusions of
participants from the
analysis
Risk of bias Could the selection of par-
ticipants have introduced
bias?
Low risk: “Yes” for all sig-
nalling questions.
High risk: “No” or “Un-
clear” for at least one sig-
nalling question
Could the conduct or in-
terpretation of the index
test have introduced bias?
Low risk: “Yes” for the
signalling question.
High risk: “No” or “Un-
clear” for the signalling
question.
Could the reference stan-
dard, its conduct, or its
interpretation have intro-
duced bias?
Low risk: “Yes” for all sig-
nalling questions.
High risk: “No” or “Un-
clear” for at least one sig-
nalling question
Could
the participant flow have
introduced bias?
Low risk: “Yes” for all sig-
nalling questions.
High risk: “No” or “Un-




Are there concerns that the
included participants and
setting do not match the
review question?
Low concern: the partic-
ipants included in the re-
view represent the partic-
ipants in whom the tests
is used in clinical practice
High concern: the par-
ticipants included in the
review differ from the
participants inwhom the
tests is used in clinical
practice
Are there concerns that the
index test, its conduct, or
interpretation differ from
the review question?
High concern: the index
test, its conduct or its in-
terpretation of the index
test differs from the way
it is used in clinical prac-
tice
Low concern: the index
test, its conduct or its in-
terpretation of the index
test does not differ from
the way it is used in clin-
ical practice
Are there concerns that the
target condition as defined
by the reference standard
does not match the ques-
tion?
-
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